Skip to main content

Genoprotective activities of plant natural substances in cancer and chemopreventive strategies in the context of 3P medicine


Severe durable changes may occur to the DNA structure caused by exogenous and endogenous risk factors initiating the process of carcinogenesis. By evidence, a large portion of malignancies have been demonstrated as being preventable. Moreover, the targeted prevention of cancer onset is possible, due to unique properties of plant bioactive compounds. Although genoprotective effects of phytochemicals have been well documented, there is an evident lack of articles which would systematically present the spectrum of anticancer effects by phytochemicals, plant extracts, and plant-derived diet applicable to stratified patient groups at the level of targeted primary (cancer development) and secondary (cancer progression and metastatic disease) prevention. Consequently, clinical implementation of knowledge accumulated in the area is still highly restricted. To stimulate coherent co-development of the dedicated plant bioactive compound investigation on one hand and comprehensive cancer preventive strategies on the other hand, the current paper highlights and deeply analyses relevant evidence available in the area. Key molecular mechanisms are presented to detail genoprotective and anticancer activities of plants and phytochemicals. Clinical implementation is discussed. Based on the presented evidence, advanced chemopreventive strategies in the context of 3P medicine are considered.


The traditional use of medicinal plants led to the discovery of numerous bioactive compounds representing potent tools in the therapy approaches and disease prevention [1]. Major benefits of isolated chemical compounds or their mixtures found in fruits, vegetables, beans, and other plant sources include anti-inflammatory, antioxidant, antibacterial, antifungal, and other health beneficiary effects [2,3,4,5,6].

Recently, plant natural substances are at the center of scientific interest due to their anticancer activity as described elsewhere [2, 7, 8]. For instance, an evidence suggests a correlation between higher consumption of phytochemical-rich foods and lower risk of cancer development [9,10,11]. Additionally, the antineoplastic efficacy of phytochemicals can be mediated via the maintenance of genome stability. Genotoxicity can be interpreted as harmful genetic changes such as gene mutations, recombination, or chromosomal aberrations in the presence of genotoxins action [12]. Multiple genomic events as a consequence of carcinogen exposures or disbalance of anti and prooxidative reactions characterize tumour evolution [13]. Healthy cells have evolved mechanisms to inactivate free radicals or carcinogenic chemicals and thus prevent DNA damage [14]. On the other hand, the imbalance and/or deficits within DNA-repair cascades can be associated with initiation, promotion, and progression of carcinogenesis [15]. Therefore, the human environment and dietary habits play a crucial role in cancer etiology [16].

Despite the use of various anticancer drugs which improve symptoms and increase patient survival, many cancers remain incurable, mainly due to advanced cancer stages diagnosed, deficient patient stratification, and neglected individualised patient profiles [17]. As such, introducing new clinical approaches reducing cancer risks would be highly beneficial for healthcare as a whole. To this end, instability of DNA structure as critical aspect of carcinogenesis under certain conditions can be chemoprevented by plant-derived bioactive compounds (phytochemicals) resulting in reduced risks of cancer development [18,19,20,21,22,23,24,25,26]. This review highlights central mechanisms of phytochemicals as natural genoprotectors, presents a spectrum of their anticancer properties, and considers their potential application for individuals at risk and patients in the context of 3P medicine, namely, predictive diagnostics, targeted primary and secondary prevention, and personalisation of treatments.

Sources of data used

English-language biomedical literature sources from PubMed database were analysed for the topic-related items including all the keywords listed above. The most recent scientific publications originated from years 2015–2020 were particularly taken into consideration for the final statement presented in the paper.

DNA damaging agents

Carcinogenesis is associated with extensive DNA damage, which is often caused by an exposure to various exogenous and endogenous agents. Thus, maintaining genomic integrity is crucial for the well-being of the organism [27]. Medication applying DNA damaging agents against cancer utilizes the biologic difference in the response between normal and tumour cells towards DNA injury, due to highly increased proliferation of the latter [28]. Figure 1 highlights exogenous and endogenous agents causing DNA damage.

Fig. 1
figure 1

Endogenous and exogenous agents causing DNA damage. Oxidative stress, production of cyclobutane pyrimidine dimers, or carcinogens exposure act as the main initiators of DNA damage. ROS, reactive oxygen species; H2O2, hydrogen peroxide; CPDs, cyclobutane pyrimidine dimers; T-T, thymine dimers; HAA, heterocyclic aromatic amines; PAH, polycyclic aromatic hydrocarbons; PhIP, 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine; IQ, 2-amino-3-methylimidazo[4,5-f]quinoline; NDMA, N-nitrosodimethylamine; DXR, doxorubicin; MMC, mitomycin C; DES, diethylstilbestrol; ETP, etoposide; MNU/NMU, N-methyl-N-nitrosourea; AOM, azoxymethane; AFB1, aflatoxin B1; IR, ionising radiation; UVA, ultraviolet A; UVB, ultraviolet B; DMBA, 7,12-dimethylbenz[a]anthracene; B[a]P, benzo[a]pyrene

Oxidative stress and reactive oxygen species (ROS)

Oxidative stress is caused by an imbalance between ROS formation and scavenging. Increased production of ROS has been detected in various cancer types with important roles in the activation of pro-tumourigenic signalling, enhancement of cell survival, and proliferation or drive of DNA damage and genetic instability [29]. Modifications of nitrogen bases in DNA or its sugar-phosphate backbone can be caused by ROS, which disrupt gene function and impair transcription, DNA replication, and cell proliferation [30]. Hydrogen peroxide (H2O2) is a relatively weakly reactive ROS and acts as a mild oxidising/reducing agent. H2O2 can oxidize DNA, lipids, and proteins mainly in increased presence of hyperreactive thiol groups or methionine residues [31]. In addition, DNA damage can be caused by inducers of ROS such as tert-butyl hydroperoxide (t-BOOH) [32]. The level of DNA damage arising from oxidative stress can be measured by analysis of level of 8-hydroxy-2′-deoxyguanosine (8-OHdG) or 8-oxo-7,8-dihydro-2′-deoxyguanosine (8-oxodG), which are widely used biomarkers for oxidative stress and carcinogenesis [33].

Cyclobutane pyrimidine dimers

An accumulation of UV-specific mutations caused by direct absorption of UV photons, such as pyrimidine dimers, is closely associated with melanoma skin cancer. UVA-induced cyclobutane pyrimidine dimers (CPDs) are formed between adjacent thymine bases, by either direct excitation or photosensitisation leading to disruption of the normal cellular processing of DNA. This DNA damage causes various biological responses including apoptosis, immune suppression, and carcinogenesis [34, 35].

Exposure to carcinogens

Exposure to carcinogens is associated with occurrence of electrophiles or ROS and can result in the cancer initiation and promotion. Carcinogens cause damage of DNA including single-strand breaks (SSBs) or double-strand breaks (DSBs), oxidative-induced lesions, covalently bound DNA chemical adducts, and DNA-DNA or DNA-protein cross-links [36]. Carcinogens are represented by heterocyclic aromatic amines (tobacco smoke, diesel exhaust, incineration ash), polycyclic aromatic hydrocarbons (roasting, grilling, baking, smoking), ultraviolet (UV) and infrared (IR) radiation, aristocholic acid, nitrosamines (drugs, cosmetics, rubber industry), mycotoxins, asbestos, and some nanoparticles [36, 37]. Specific examples of carcinogens and their DNA damaging mechanisms are summarised in Table 1.

Table 1 Specific groups of carcinogens and their DNA damaging mechanisms

Molecular mechanisms involved in genoprotective action

Damage of DNA is essential for the induction of mutations associated with initiation, promotion, and progression of carcinogenesis [15]. Accordingly, healthy cells must be defended against DNA damage caused by endogenous and exogenous agents and decrease the mutagenic processes. As discussed below, molecular mechanisms of genoprotective agents are involved in the protection against DNA damage.

Antioxidant activity

ROS directly oxidize DNA and interfere with various mechanisms of DNA repair, triggering DNA chain breaks, base modification, and other oxidative DNA lesions [56]. In cancer management, ROS scavenging is an important antioxidant mechanism with an effort to reduce tumour growth and survival of cancer cells and can be achieved by different types of plant-derived phytochemicals [57,58,59]. ROS can be scavenged via either enzymatic or non-enzymatic pathways such as glutathione (GSH), thioredoxin (Trx), superoxide dismutase (SOD), catalase (CAT), and peroxidases [60, 61].

Cellular defense against oxidative stress is mediated mainly by an activation of the Nrf2-antioxidant response element signalling pathway. Under physiological conditions, the Nrf2 expression is regulated through the binding to Keap1 which is associated with Nrf2 degradation [62]. On the contrary, upon oxidative stress, this binding is interrupted and Nrf2 can translocate to the nucleus and bind an antioxidant response element (ARE) sequences that are present in enhancer regions of cytoprotective genes. Subsequently, these genes encode enzymes and proteins with the function in the balance of redox homeostasis and detoxification oxidants or electrophiles. Furthermore, cytoprotective genes code an ability to remove or repair damaged DNA and proteins [63,64,65].

Nrf2-independent pathway is involved in the protection against ROS-induced DNA damage. Aryl hydrocarbon receptor (AhR) is defined as ligand-activated transcription factor, which binds to exogenous ligands leading to nuclear translocation of AhR and consequent dimerisation with associated AhR protein. A subsequent interaction between the heterodimer with consensus DNA sequence xenobiotic responsive element and the enhancer regions of target genes increases their transcription [37, 66]. Inactivation of carcinogens, such as B[a]P by phytochemicals, can lead to the protection against DNA damage as was demonstrated in several studies concerning cancer chemoprevention and therapy [67,68,69].

Under specific cellular conditions, antioxidants can also act as prooxidants, which promote production of ROS, subsequently cause different DNA damage and initiate mutagenesis. To determine the prooxidant status, the concentration of several reductant-oxidant markers, including glutathione (GSH) to GSSG, NADPH to NAPD, and NADH to NAD, has to be evaluated [70]. The prooxidant activity is catalysed by metals, especially transition metals present in biological systems such as iron (Fe) and copper (Cu) [71]. The prooxidant effect was observed in numerous phenolic compounds including flavonoids [72, 73]. Moreover, cytotoxic level of ROS caused by prooxidant compounds is increased in cancer cells probably due to the higher concentration of iron/copper ions and greater metabolic activity compared with normal cells [74]. Inhibition of prooxidative enzyme activation, including the GSH, thioredoxin (TXN), or NADPH oxidase, can represent a potential target in cancer prevention and treatment [75, 76].

Detoxification processes

In mammals, metabolic activation of phase I and phase II enzymes is involved in liver detoxification of various classes of environmental carcinogens. These enzymes can enhance the elimination of carcinogens and protect DNA against damage [77, 78]. Cytochrome P450 (CYP) is the main enzyme of phase I detoxification, which converts xenobiotics to active intermediates [79]. In tumour tissues, CYP cause resistance by metabolising and, therefore, targetly deactivating the cytostatics [80]. Phase II detoxification enzymes, including glutathione S-transferases (GSTs), NAD(P)H:quinone oxidoreductase 1 (NQO1), and heme oxygenase-1 (HO-1), catalyze the conjugation of these active intermediates by sulfation or glucuronidation [81]. Moreover, GST activity can apparently influence DNA stability and repair process towards oxidised bases [82].

Cellular mechanisms of antioxidant defense system and detoxification are included in Fig. 2.

Fig. 2
figure 2

Antioxidant and detoxifying processes involved in genoprotective activities. Part A demonstrates the metabolic processes of phase I (Cytochrome P450) and phase II (GSTs, NQO1, HO-1) enzymes involved in detoxification of environmental carcinogens. Part B describes the ROS scavenging activity via either enzymatic or non-enzymatic pathways, Nrf2-antioxidant response element signalling pathway, and AhR-dependent pathway. SOD1, superoxide dismutase 1; SOD2, superoxide dismutase 2; SOD3, superoxide dismutase 3; H2O2, hydrogen peroxide; GSH, glutathione; GR, glutathione reductase; GSSG, glutathione disulfide; NADP, nicotinamide adenine dinucleotide phosphate; XO, xanthine oxidase; AhR, aryl hydrocarbon receptor; Nrf2, nuclear factor erythroid 2-related factor 2; KEAP1, Kelch-like ECH-associated protein 1; TRX, thioredoxin; GRX, glutaredoxins; ARE, antioxidant response element; XRE, xenobiotic response element

DNA repair mechanisms

In case of a mild damage of DNA (the repair of DNA is possible), various signalling cascades are activated by cells to restore the original genetic information. Genetic mutations in genes coding the DNA repair may contribute to the cancer initiation. DNA damages, such as DSBs and SSBs, activate pair of related protein kinases ATM and ATR, respectively. In case of mutations, ATM and ATR phosphorylate several common substrates leading to an initiation of a cascade resulting in cell cycle arrest and DNA repair [83].

The simplest process to repair SSBs induced by ROS is base excision repair (BER). DNA repair of base damage via BER is provided by four enzymes including a DNA glycosylase, AP-endonuclease I (APE1), DNA polymerase β (Polβ), and a DNA ligase [84, 85]. OGG1 is a repair enzyme 8-oxoGua DNA glycosylase 1 that removes the oxidised purine from DNA as the first step in BER. AP endonuclease bypasses the AP lyase activity of OGG1, thus enhancing OGG1 turnover (APE1) [18]. Moreover, other repair mechanisms, such as two types of nucleotide excision repair (NER) and DNA mismatch repair (MMR), are closely linked to cancer cells. In transcription-coupled nucleotide excision repair (TC-NER), DNA damage is recognised by XPC enzyme and the double strand of DNA is subsequently unfolding from both sides through the presence of helicases XPA, XPG, and TFIIH. Damaged DNA is removed and the synthesis of a new strand can start [86]. Furthermore, other global genomic nucleotide excision repair (GG-NER) mechanisms may repair damage in transcribed or untranscribed DNA strands throughout the genome [87]. Small loops in DNA can be recognised and repaired by MMR either by base-base mismatches or by insertion/deletion loops [88]. NER and BER systems repair damages affecting just SSBs and the lesions involving exogenous and endogenous sources, respectively [89].

More problematic DSBs are primarily repaired by error-free pathway called homologous recombination (HR) operating in the S and G2 phases of the cell cycle and non-homologous end joining (NHEJ), which tends to be error prone and acting in all phases of the cell cycle [90]. Responsibility for genome instability of cells is due to the disruption of many alternative but highly error prone DNA DSB repairs such as single-strand annealing (SSA), microhomology-mediated end joining (MMEJ), and NHEJ [91, 92]. SSA pathway is a mutagenic DSB repair pathway in comparison with error-free HR during S/G2 phases [93]. These error prone DSB repair mechanisms can lead to carcinogenesis [94, 95]. Activation of error prone DNA-repair signalling pathways is involved in the resistance of tumour cells to therapies. An inhibition of these repair mechanisms shows a potential in anticancer treatment [89]. Figure 3 overviews the repair mechanisms, which are involved in the protection against various DNA damage.

Fig. 3
figure 3

Repair mechanisms involved in genoprotective activities. Mutation causes the phosporylation of substrates by ATM and ATR recognising DSBs and SSBs, respectively. SSBs are associated with three different repair mechanisms including NER (TC-NER and GG-NER), BER, and MMR. DSBs can be repaired primarily via error-free HR but in case of defect of HR, error-prone SSA, NHEJ, or MMEJ are involved in repair. ssDNA, single-strand DNA; dsDNA, double-strand DNA; ROS, reactive oxygen species; HR, homologous recombination; SSA, single-strand annealing; MMEJ, microhomology-mediated end joining; NHEJ, non-homologous end joining; MMR, DNA mismatch repair; BER, base excision repair; NER, nucleotide excision repair; ATM, protein kinase ataxia-telangiectasia mutated; ATR, ataxia telangiectasia and Rad3-related protein; OGG1, 8-oxoguanine glycosylase; APE1, human apurinic/apyrimidinic endonuclease 1 Polβ, polymerase β; GG-NER, global genomic nucleotide excision repair; TC-NER, transcription-coupled nucleotide excision repair; XPC, CSA, Cockayne syndrome group A protein; CSB, Cockayne syndrome group B protein; RNAPII, RNA polymerase II; XPA, DNA repair protein complementing xeroderma pigmentosum-A cells; XPG, DNA repair protein complementing xeroderma pigmentosum-G cells; TFIIH, transcription factor II H

Genoprotective activities of plant natural compounds evaluated in preclinical research

Phytochemicals, either as single substances or their mixtures present in plants, have recently been a highly topical issue of cancer research. Additionally to the significant anticancer properties of plant compounds in already initiated process of carcinogenesis in vitro, in vivo, or in clinical sphere [96,97,98,99,100], their widespread use in cancer chemoprevention should not be forgotten. Plant natural compounds exhibit significant genoprotective effects such as protection against DNA damage, detoxification of carcinogens, or induction of DNA repair [101, 102].

Antioxidant activity of plant natural substances

Non-cancer models

The protective efficacy of whole natural substances against DNA damage was evaluated in several preclinical studies. As examples, we can describe a tropical plant Chrysobalanus icaco L. (CHI) exerted antigenotoxicity in peripheral blood cells, antimutagenicity in bone marrow cells and peripheral blood cells, and decreased oxidative stress in peripheral blood neutrophils in Wistar male rats after doxorubicin (DXR)-induced DNA damage and generation of ROS. Chemopreventive efficacy of CHI was noted as an inhibition of NADPH oxidase complex with low levels of DNA damage in rats after DXR exposure. Antunes with co-authors (2016) stated that the genoprotective effect against DXR-induced DNA-damage in vivo was attributed to the phytochemicals and minerals present in CHI exhibiting strong antioxidant properties [103]. Lemongrass essential oil (LEO) that consists mainly of citral (68.78 %) demonstrated several pharmacological, mostly anti-oxidant, and cancer preventive activities. LEO protected human embryonic lung fibroblasts (HELFs) against B[a]P-induced loss of cell viability. Moreover, untreated HELFs exposed to B[a]P showed an increased activity of malondialdehyde (MDA) and a reduced activity of CAT and SOD. Importantly, opposite effect in enzyme activities was observed in HELFs treated with LEO. Additionally, an efficacy of LEO to decrease DNA damage was proven by reduction of 8-OHdG level, indicating LEO as a promising agent in lung cancer chemoprevention [104].

Additionally, Allium cepa L. and A. × cornutum Clementi ex Visiani are common onions which contain large amount of flavonoid quercetin that shows a specific role in different biological processes including cancer [105, 106]. Studies of the DNA protection revealed that the presence of both methanolic extracts of A. cepa L. and A. cornutum reduced DNA damage, especially DNA strand breaks in human leukocytes. Antioxidant activity was observed in both extracts but slightly higher for Allium cornutum due to the higher phenolic content. In DNA nicking assay generated by Fenton reaction, higher concentration of extracts demonstrated significant scavenging activity of free radicals and the ability to maintain DNA in supercoiled structure. Due to high level of quercetin, Allium cornutum and A. cepa proved to catch and inactivate hydroxyl radicals in H2O2-induced DNA damage in human leukocytes. On the contrary, higher dose of Allium cornutum and A. cepa can also provoke oxidative DNA damage mainly by structural characteristics of phenolic compounds which can concurrently play a role as antioxidants and prooxidants. Authors concluded a protective role of A. cepa and A. cornutum on DNA strand breaks via the antioxidant activity [106]. Furthermore, Euphorbia dracunculoides methanol extract (EDME) revealed hepatoprotective and genoprotective effects against oxidative stress and genotoxicity induced with CCl4 in the liver of Sprague-Dawley male rats. Administration of EDME in diet of rats increased the levels of antioxidant enzymes (CAT, peroxidase (POD), and SOD), and phase II enzymes (GST and GSH) in liver tissues after CCl4 injection compared with control. Similarly, EDME decreased the level of lipid peroxides such as thiobarbituric acid reactant substances (TBARS), nitrite, and hydrogen peroxide in liver tissue. Moreover, decline in the level of DNA damage, including DNA strand breaks caused by CCl4, was observed in hepatocytes of EDME-treated rat group compared with control [107].

Cancer models

Brachystegia eurycoma (BE) from South Eastern Nigeria also known as “Achi” prevented N-methyl-N-nitrosourea (MNU)-induced increasement of MDA and carcinoembryonic antigen (CEA). Chemopreventive study on male Wistar rats demonstrated the hard-mucosal ulceration in the colon associated with inter-glandular inflammation in control group with a single treatment of MNU. On the other hand, only moderate or even no inflammation in the colon in the MNU groups pretreated with BE was detected. Furthermore, studies on the colon revealed that the BE pretreatment to great extent prevented MNU-induced DNA damage to mismatch repair gene MutL homolog1 (MLH1) [108], which mutations are considered biomarkers of carcinogenesis [23]. Furthermore, histological analysis showed oxidative damage in the MNU control group, but not in BE pretreated groups. Moreover, a good correlation was detected between the MLH1 expression and the CEA (r = 0.361, p < 0.05). Results suggested strong genoprotective activity in the colon via the high antioxidant potential of BE intake [108].

Another study, focused on bioactive compounds of Butea monosperma (Lam.) which contains chalcones butein, and isobutrin, and flavonoid butrin, demonstrated anticancer activities [109, 110]. An antioxidant activity of different extracts of B. monosperma was measured by DPPH assay. Chloroform and ethyl acetate extracts exhibited pronounced antioxidant activity. Both extracts were shown to protect plasmid DNA of E. coli plasmid pBR322 against hydroxyl radical induced DNA damage. Extracts also exerted antiproliferative properties and apoptotic activity through the cell cycle arrest in G1 and sub-G1 phase, enhanced ROS levels, and induced DNA DSBs in MCF-7 breast carcinoma cells [111]. Furthermore, extracts from wines and grapes are rich in polyphenols which can modulate colonocyte mutagenesis and subsequently prevent tumour initiation and promotion [9]. A powdered red wine pomace seasonings (RWPSs) (Sk-S: seedless, W-S: whole, Sd-S: seeds) demonstrated the genoprotective effects against oxidative DNA damage in HT-29 cells [112]. An ability to prevent DNA against oxidative damage via RWPSs was enhanced progressively along digestion resulting in differences from undigested (UD) to colonic fermented (CF) fractions for W-S and between all fractions for Sd-S. In addition to genoprotective effects, the study also determined the antigenotoxic and antiproliferative efficacy of RWPSs in HT-29 colon cancer cells with potential in cancer chemoprevention [112].

Glucosinolates, abundantly presented in Brassica vegetables, are hydrolysed during digestion to different products including indole-3-carbinol (I3C). Under acidic condition. I3C polymerizes to indolo[3,2-b]-carbazole (ICZ) [113] with potential anticancer efficacy. An influence of ICZ in the protection against oxidative DNA damage was evaluated in Caco-2 colon carcinoma cell line. The level of DNA strand breaks after pretreatment with ICZ and subsequent exposition to genotoxins t-BOOH, H2O2 or B[a]P that produce oxidative stress was diminished in Caco-2 cells. On the other hand, simultaneous addition of ICZ did not protect against t-BOOH-induced strand break formation leading to disproof of the direct radical scavenging effect. Interestingly, ICZ did not play a role in SSB repair through the BER, which was not associated with altered expression of BER proteins such as OGG1, APE, PARP1, and XRCC1 in Caco-2 cells. Moreover, ICZ activated ROS scavenging effect with proven low level of 8-OHdG in pretreated Caco-2 cells; however, the antioxidant response pathway of ICZ was independent of Nrf2. It was demonstrated that ICZ activated AhR being protective against oxidative DNA damage in Caco-2 cells. The results suggest that the AhR-dependent pathway was associated with protective activity against ROS-induced DNA damage in colorectal carcinogenesis, and was independent of the Nrf2 pathway [20].

MDA is often used as a marker of the oxidative damage of lipids by free radicals. Recently, we have found that dietary administered clove buds, thyme, and cinnamon, rich in antioxidants, decreased the MDA level in mammary cancer cells in vivo [2, 7, 114,115,116]. Moreover, young barley leaves and fruit peels polyphenols also lowered the levels of dityrosines, the product of oxidative stress, in mammary cancer cells in vivo [114]. Our results indicated significant antioxidant effects of these plant natural substances in rat carcinoma models and indicated potential genoprotective mechanisms and chemopreventive activity in mammary carcinogenesis.

Detoxification processes via plant natural substances

Non-cancer models

Administrating Crataegus songarica methanol extract (CSME) to rats demonstrated antitumour activity, protection against DNA damage, and protection of the kidney and heart tissue against CCl4-induced toxicity. CSME decreased serum creatinine, urea, cholesterol, and MDA level in the kidney and heart tissue. The suppression of GSH, GR, GPx, and GST enzyme activity was also detected in both the kidney and heart tissue. In addition, CSME showed protective effect against CCl4-induced DNA damage of kidney and heart tissue [117].

Cancer models

Sage tea (Salvia officinalis, SO) demonstrated a chemopreventive effect against azoxymethane (AOM)-induced preneoplastic lesions of colon cancer in vivo. Comet assay revealed that SO treatment protected DNA against AOM-induced or H2O2-induced damage in colonocytes isolated from female rats. Moreover, SO decreased the proliferation marker Ki67 in the colon. Interestingly, effects of SO in the inhibition of cancer initiation were not proven by increased excretion through GST induction or decreased bioactivation by cytochrome P450 2E1 (CYP2E1) in liver homogenates. Results indicated that the consumption of SO tea may prevent the development of colon cancer via various mechanisms such as protection against DNA damage and modulation of cell proliferation resulting in prevention of mutations and their fixation through the cell replication [118]. Thymus revolutus Célak essential oil (TRCEO) and its two main constituents, γ-terpinene and p-cymene, have been demonstrated as potential as oxidative agents in lung cancer cells (H1299 and A549) and epidermoid carcinoma cells (A431). Activity of antioxidant enzymes in cancer cells was depended on concentration of TRCEO components and prooxidant/antioxidant effects of extract. IC50 and IC70 concentrations of TRCEO, γ-terpinene, and p-cymene caused oxidative stress. Parental H1299 cells were the most sensitive to the cytotoxic effects of all tested compounds. The highest membrane and DNA damages were observed in A431 and A549 cells, respectively. TRCEO, γ-terpinene, and p-cymene increased the MDA levels and 8-OHdG formation in all cancer cells used. Additionally, they increased glutathione reductase (GRx), glutathione peroxidase (GPx), GST, and glucose 6-phosphate dehydrogenase (G6PD) activity. These compounds demonstrated antitumour and prooxidative effects with subsequent induction of cytotoxic death of cancer cells [119]. Flaxseed consumption reduced oxidative stress and inflammation in tobacco smoke carcinogen (NNK)-induced lung tumourigenesis in A/J mice. Noteworthy, 10 % flaxseed in the diet altered expression of several CYPs, GSTs, and UDP-glucuronosyltransferase (UGTs). Flaxseed also reduced expression of pro-inflammatory cytokines (IL-1α, IL-6, IL-8, and IL-9) and increased the expression of anti-inflammatory cytokine (IL-12α) in lung tissues suggesting chemopreventive properties of flaxseed elicits and associated detoxification of NNK [120].

Methanol extract of Pongamia pinnata seeds (MEPPS) and its secondary metabolites pongapin and lanceolatin B showed chemopreventive potential due to their ability to inhibit CYP1A1 and protect CYP1A1-overexpressing HEK293 human embryonic kidney cells against B[a]P-induced toxicity. Additionally, MEPPS and its metabolites also induced the G0-G1 phase cell cycle arrest of CYP1A1-overexpressing MCF-7 breast cancer cells, and suppressed cyclin D1 levels leading to cellular senescence [121].

DNA repair mechanisms via plant natural substances

Non-cancer models

Several studies were focused on genoprotective activities associated with various plant extracts. Extract of Sechium edule (SEE) fruit from Cucurbitaceae family is rich in amino acids, saponins, sugars, and flavonoids [122]. Genoprotective activities of SEE against UVA-induced DNA damage in normal human keratinocytes (NHK) were evaluated. SEE increased DNA repair capacities, the maintenance of proliferation, and preservation of stemness property of NHK after UVA exposure. Furthermore, SEE reduced UVA-induced oxidative DNA damage by 30 % compared with control. Oxidised DNA bases modified by ROS in NHK with SEE treatment were repaired via the BER pathway. The upregulation of BER genes OGG1 and MYH in mRNA levels was detected; however, the expression levels of APE1, POL β, LIG3, UNG, and XRCC remained unchanged. Noteworthy, global DNA repair pathways were influenced not only through BER but also through the NER pathway with positive impact on the repair of small oxidative DNA lesion and photoproducts in NHK. Moreover, an amount of CPD, predominant DNA lesions after UVA irradiation in human skin [123], was undoubtedly increased in untreated NHK. On the contrary, number of CPD after UVA exposure was reduced in NHK treated with SEE suggesting the stimulation of repair of such photoproducts [124]. Ficus carica leaf extract (FCE), which is native to Egypt or Western Asia, reduced DNA damage and reversed non-steroidal estrogen (DES)-induced DNA damage, especially strand breaks in non-tumourigenic MCF10A human breast epithelial cell line. FCE stimulated DNA repair and optimised comet formation resulting from the irreversible interaction of oxidative quinine metabolites of DES (DESQ) with the nuclear apparatus causing DNA damage [125], keeping in mind DES binds to both estrogen receptors ER-ɑ and ER-β [126]. Overall, the study demonstrated both a chemopreventive and cancer therapeutic role of FCE in early-stage breast cancer [125].

Cancer models

Hemidesmus indicus (L.), also known as Indian sarsaparilla, is an Indian weed with healing effects of the crude root in Ayurvedic medicine [127]. Study evaluating the cancer chemopreventive and therapeutic potential demonstrated the genoprotective effects of H. indicus hydro-alcoholic extract (HIHE) in pre-, co-, and post-treatment in DLD1 colorectal adenocarcinoma cells and in CCRC-CEM T-lymphoblastic cells. Genoprotective properties were evaluated after exposure to genotoxic agents such as etoposide, DXR, and H2O2. HIHE soxhlet strongly reduced the genotoxicity of etoposide associated with a reduction up to 47.3 %, 42.6 %, and 29.2 % in the H2AX phosphorylation in the pre-, co-, and post-treatment, respectively. Similar effect was observed after treatment with DXR and H2O2. HIHE pre-treatment played a critical role in genoprotective activity against DNA damage. Additionally, HIHE significantly decreased the cell viability and cell proliferation demonstrated via reduced Ki67 levels in DLD1 and CCRC-CEM cells. Moreover, the cell cycle arrest in S phase for low concentration and G2/M arrest for higher concentration was observed after 24-h HIHE treatment in CCRC-CEM cells. Results suggested that several mechanisms can be involved in genoprotective activity of HIHE by reducing the rates of absorption and uptake of the genotoxic agent and by modulation of DNA repair, cell cycle, or apoptosis at extra- and intracellular level [128].

Isolated phytochemicals from plants also demonstrated genoprotective action in cancer chemoprevention and treatment. FANCA proteins are key players in the canonical Fanconi anemia (FA) repair pathway with impaired response to DNA damage through the HR. Predisposition to breast cancer, including mutation in BRCA1 and BRCA2 (one of the FA protein) gene, is mainly due to disruption of many DNA DSB repairs. High FANCA expression supports the survival of cancer cells despite the DNA damage with subsequent genomic instability via SSA repair. Withaferin A (WA) is a steroidal lactone isolated from winter cherry (Withania somnifera (L.) Dunal) that has an ability to reduce FANCA protein levels and downregulates HSP90 expression in MDA-MB-231, SUM-149, MCF-7 breast cancer cells, and U2OS osteosarcoma cells as a platform of DSB repair reporter assays which demonstrated the disrupted interaction between FANCA-HSP90. Additionally, these processes were associated with a defect in WA-induced SSA repair, abolition of FANCD2 monoubiquitination, increased sensitivity to mitomycin C leading to accumulation of DSBs. Despite that FANCA and RAD52 are the major catalytic factors in the SSA subpathway of DNA DSB repair, WA reduced only FANCA but not RAD52 level. In conclusion, defect in SSA repair induced by WA is dependent on the FANCA protein absence. Moreover, overexpression of exogenous WT-FANCA protein complements the repair defect in WA-treated cells [21].

Taken together, the above studies demonstrate that plant natural substances exert potential genoprotective activities in vitro and in vivo, which suggest their application in chemoprevention of various cancer types (Table 2).

Table 2 Genoprotective activities of plant natural substances in preclinical non-cancer and cancer models

Plant bioactive compounds formulated as nanoparticles

Nanotechnologies represent modern multidisciplinary and interdisciplinary approach connected with many applications in scientific research [129, 130]. As detailed above, phytochemicals have a promising potential for human health in preventing or treating various civilisation diseases, including malignant transformation [99, 131, 132]. However, few undesirable aspects, such as their low solubility in water, low stability, or some side effects, are associated with higher doses of plant bioactive compounds and limit their application [133,134,135]. However, nanoparticles are able to eradicate these processes [129], which are important in the maintenance of genomic stability. Consequently, some studies predicted that green synthesis of nanoparticles is an innovative and future treatment strategy against tumour initiation, promotion, or progression [136,137,138,139].

Recently, an antigenotoxic effect of biosynthesised silver nanoparticles (SNPs) of Ocimum sanctum leaf extract against cyclophosphamides (oxazaphosphorines acting as the alkylating agents) has been analysed. Biosynthesised nanoparticles of O. sanctum exerted a protective effect on the human lymphocytes after cyclophosphamide intervention. SNPs at concentrations of 50, 100, and 200 μl/ml demonstrated a significant decrease in chromosomal damages compared with controls. Higher level of a mitotic index of treated lymphocytes was also observed as a consequence of the protection role green SNPs in genome stability [25]. Genoprotective abilities of green-synthesised selenium nanoparticles of Terminalia arjuna leaf extract against arsenic-induced genotoxicity and cell death were analysed in human lymphocytes. Acquired data revealed a reduction of arsenic-induced DNA damage in lymphocytes after the treatment by selenium nanoparticles [22]. Moreover, genoprotective effect of leaf extract of lemon plants used in green-synthesised colloidal selenium nanoparticles was demonstrated after UV-induced DNA damages in human lymphocytes, and could be used as potential chemotherapeutic tool [140]. Also, apigenin combined with poly-(lactide-co-glycolide) acid (PLGA) nanoparticles decreased the chromosomal aberrations in B[a]P- and UVB-induced skin cancer in vivo [19]. Interestingly, the bioavailability of tea polyphenols (TPs) was improved by chitosan and bovine serum albumin (BSA) nanoformulation in mice. Animals were fed by nanoparticles for 3 days before irradiation exposure leading to enhancement of DNA stability via the reduction of oxidative damage [141]. Similarly, silver nanoparticles in combination with glycyrrhizic acid protected Swiss albino mice against ionising radiation, by decrease of DNA strand breaks formation and increase in their repairs [142]. Moreover, theaflavin (TF) and epigallocatechine-3-gallate (EGCG) in PLGA nanoparticles exhibited a higher DNA protection compared with TF and EGCG without nanocarrier in 7,12-dimethybenz[a]anthracene (DMBA)-induced DNA damage in mouse skin [143]. Finally, PLGA-encapsulated Phytolacca decandra showed the chemopreventive effect with impact on DNA fragmentation, comet tail length, and level of biomarkers such as NFκB, p53, PARP, ROS generation, CYP1A1, and caspase-3 in mouse model intoxicated with B[a]P + sodium-arsenite [144].

Paradoxically, potential toxicity based on DNA oxidative damage is associated with silver nanoparticles used in many areas, including food, medical, and healthcare [145,146,147]. However, phytochemicals could counter this effect, as it was described by the use of methanolic and aqueous extract of Gentiana asclepiadea, which prevented toxicity of silver nanoparticles treatment in human kidney HEK293 cells [148].

Clinical research evaluating genoprotective activities of phytochemicals

Consumption of diet rich in substances of plant origin, such as cruciferous vegetable, kiwifruits, fruit juice, or diet of Mediterranean pattern, as well as beverages including tea or coffee, is associated with potent cancer preventive properties. The importance of genoprotective abilities of plant substances was evaluated in clinical, mainly preventive studies conducted on healthy or high-risk individuals [18, 24, 26, 149,150,151,152,153,154,155,156,157,158].

Antioxidant properties of phytochemicals

A mixed berry juice rich in anthocyanin/polyphenolics decreased oxidative DNA damage and increased level of reduced glutathione (GSH) and glutathione status in cells of healthy participants while the observed decrease in oxidative DNA damage may be associated with direct antioxidant effects such as ROS scavenging or chelation [150]. Similarly, the decrease in cancer risk due to the reduction of lymphocyte DNA damage and alterations in the blood antioxidant status in healthy adults was associated with the consumption of watercress-based supplementation. Interestingly, the beneficial effects of the supplementation were more significant in smokers than in non-smokers [149]. Furthermore, kiwifruit protected healthy non-smokers against oxidative DNA damage, upregulated the level of antioxidant activity, and stimulated DNA repair, which appears to be a result of an increased stability of the OGG1 protein or availability of an unknown co-factor and not by altered gene expression of OGG1 or APE1. Interestingly, these changes were not related to the number of kiwifruits consumed [18]. Three-month administration of the antioxidants ascorbic acid (vitamin C) and D-α-tocopherol (vitamin E) in volunteers with history of melanoma or no UV-induced skin cancer increased antioxidant capacity of skin as demonstrated by a significant decrease in thymine dimmers induced by the UVB irradiation [158]. Additionally, green tea polyphenols (GTP) decreased level of 8-OHdG in individuals with high risk of liver cancer [151].

Phytochemicals protecting against carcinogen-induced DNA damage

Cooked Brassica carinata (no allyl isothiocyanate, AITC) reduced DNA damage induced by aflatoxin B1 (AFB1) in peripheral blood mononuclear cells of healthy participants exposed to aflatoxin B1 with or without metabolic activation using human S9 mix when compared with baseline. Raw B. carinata (AITS-containing) led to the reduction of DNA damage by S9 activated AFB1 only. However, any changes in plasma antioxidant capacity were not observed in any group, which was possibly a result of no changes in the content of total polyphenols due to cooking procedure. Moreover, the bioavailability of phenolics may increase as a result of short-term cooking of some vegetables. Above all, antigenotoxic efficacy of B. carinata in healthy participants is not primarily mediated by AITS due to the absence of AITC metabolites in plasma or urine of subjects who consumed the cooked B. carinata leaves [152]. Further, the consumption of a hop flavonoid xanthohumol (XAN) was associated with preventive properties against DNA damage induced by dietary carcinogens in healthy non-smokers. XAN substantially decreased B[a]P- and 2-amino-3-methylimidazo[4,5-f]quinoline (IQ)-induced DNA damage while moderate protective effects were associated with N-nitrosodimethylamine (NDMA) suggesting an important protective efficacy of XAN against carcinogens detoxified by α-GST that represents major groups of dietary carcinogens [154]. Moreover, coffee induced GSTP, a member of GST isoenzymes, and protected lymphocytes of healthy subjects against DNA damage induced by (+/-)-anti-B[a]P-7,8-dihydrodiol-9,10-epoxide (BPDE), the DNA-reactive metabolite of B[a]P [155]. Similarly, brussel sprouts protected peripheral human lymphocytes of healthy participants against 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) possibly via the inhibition of sulfotransferase 1A1, a key enzyme participating in the PhIP activation. Moreover, the reduced oxidative DNA damage due to the presence of compounds acting as direct ROS scavengers was also attributed to the consumption of sprouts [156].

High-phenol extra-virgin olive oil (EVOO) could be at least partially associated with lower mortality or incidence of cancer in regions characterised by Mediterranean diet. Actually, the reduction of DNA damage was observed in healthy postmenopausal women after the consumption of a high-phenol EVOO [24]. Similar results were observed after a consumption of carotenoid supplementation suggesting that the combination of carotenoids (in doses easily achieved by the diet) possesses protective abilities against DNA damage [26]. Anticarcinogenic properties of cruciferous vegetables are associated with improvement in cell protection against DNA damage. The study evaluating protective effects of broccoli in healthy young male revealed significant decrease in strand breaks in both smokers or nonsmokers and reduction of oxidised purines in smokers [157].

Accordingly, an intake of natural substances, which exert potential genoprotective properties and subsequent chemopreventive abilities against several cancer types, should represent a significant and important element of everyday diet. Due to the presence of health-threatening compounds in the human environment, we emphasize a significant protective effects of phytochemicals against damage leading to carcinogenesis in both healthy and high-risk individuals (Table 3).

Table 3 Genoprotective properties of plant natural substances in clinical cancer research

The significant genoprotective abilities of plant natural substances in preclinical, clinical, and nanotechnology approach described above are summarised in Fig. 4.

Fig. 4
figure 4

Overview of plant natural substances which are associated with genoprotective abilities in preventive and therapy studies. SO, Salvia officinalis; RWPSs, powdered red wine pomace seasonings; LEO, lemongrass essential oil; CHI, Chrysobalanus icaco; SEE, Sechium edule extract; HIHE, Hemidesmus indicus hydro-alcoholic extract; FCE, Ficus carica leaf extract; BE, Brachystegia eurycoma; AC and AXC, Allium cepa L. and Allium × cornutum; BM, Butea monosperma; WA, withaferin A; ICZ, indolo[3,2-b]-carbazole; EDME, Euphorbia dracunculoides methanol extract; CSME, Crataegus songarica methanol extract; TRCEO/γ-T/p-C, Thymus revolutus Célak essential oil/γ-terpinene/p-cymene; FLAX, flaxseed; MEPPS/PONG/LanB, methanol extract of Pongamia pinnata seeds/pongapin/lanceolatin B; YB, young barley; CB, clove buds; THY, thyme; FPP, fruit peel polyphenols; CIN, cinnamon; vit. C and vit. E, vitamin C (ascorbic acid) and vitamin E (D-α-tocopherol); GTP, green tea polyphenols; A/PFJ, anthocynin/polyphenolic-rich fruit juice; EK, Ethiopian kale (Brassica carinata); EVOO, extra-virgin olive oil; XAN, xanthohumol; SNPs, silver nanoparticles; GA, glycyrrhizic acid; TF, theaflavin; EGCG, epigallocatechine-3-gallate; PLGA, poly (lactide-co-glycolide) acid; TP, tea polyphenols; BSA, bovine serum albumin; APIG, apigenin; SeNPs, selenium nanoparticles

Protective and toxic interactions in the clinical setting

The secondary effects of oncological treatments, in terms of chemo- and radiotherapy, and its management have been widely addressed in multiple publications since their very beginnings [159,160,161]. Different pharmaceutical options, in a variety of presentations, are currently available for toxicity management according to the affected region or tissue, and their use has been included and recommended in various practice guidelines [162, 163]. However, not many studies have addressed the potential benefits of natural compound utilisation as a scientifically validated approach [164]. This resembles an important topic to be evaluated, as depending on factors such as the geographical provenance or cultural background, the association between occidental and traditional medicine could be a factor to consider in treatment decision-making [165, 166]. It should be as well taken into account that nearly 2 % of cancer deaths might be directly related to X-ray exposure; therefore, major efforts to generate further knowledge in this topic are warranted [167].

Several mechanisms to explain the chemo- or radio-protective effect of plant-based management have been postulated. The high polyphenol content found in plants might be one of the substances mediating the cytoprotective effect. Through it, antioxidant enzymes may upregulate mRNA, diminishing the oxidative response after radiation exposure; additionally, DNA repair genes upregulation could contribute ameliorating failures in double-strand repairing [168]. Additionally, generating reactive oxygen species and apoptotic pathways induction has been as well described as associated mechanisms [169].

Implicancies in radiation protection

On this molecular basis, different studies have been conducted in order to prove its clinical impact. An investigation developed in the setting of cancer staging scans analysed the impact of multi-agent antioxidant pills administrated before Tc99 isotope application, containing ascorbate, n-acetylcystein (NAC), lipoic acid, and beta carotene. DSBs were measured both before and after imaging and compared between a control group and an interventional group. A significant DSB 60 % reduction was observed in the interventional group [170].

The expected profile of radiotherapy toxicity is quite known according to the irradiated tissue, delivered dose, volume of treatment, amongst other factors [171]. Radioprotectors, such as Amifostine, have proven to be efficient in management, for example, of head and neck cancer treatment-related toxicity; however, its availability and implementation in clinical routine due to logistics or elevated costs could impact its accessibility [172, 173]. On the contrary, natural compounds or phytochemicals could be found widely across the globe, although safety, dosing, and outcome data persist to be currently scarce. Preliminary evidence of the effect of coffee (n = 75), Matricaria recutita (n = 52), Aloe vera (n = 61), and Calendula officinalis (n = 40) have shown a positive and statistical significant impact in oral mucositis reduction in prospective studies, although it is worth remarking that these investigations might present selection bias [174,175,176]. In the setting of breast cancer, the protective effect of 6 g per os of curcumine was assessed throughout the course of radiotherapy, randomised in a small cohort of 30 patients. The evaluated endpoint was moist desquamation, which was positive in 28.6 % against 87.5 % for the interventional and control groups, respectively [177].

Negative interactions between plants or phytochemicals and radiotherapy have not been widely addressed and current information regarding this topic remains sparse. In general terms, only low-quality data showing no toxic crossed-interactions has been to date reported [178, 179]. However, caution must be taken for smoker patients during radiotherapy. The administration of antioxidants to this particular subgroups of patients has shown in a randomised trial, that it could carry an increased recurrence and mortality rate risk (HR 2.42 and 2.26, respectively) compared with the control non-interventional group, probably due to an elevation of seric carboxyhemoglobine, thus decreasing the oxygen-dependant radiotherapy effect [180, 181].

In addition, further research is being currently carried towards clarifying the radiosensitizer role of phytochemicals such as flavonoids, in order to enhance radiotherapy´s therapeutical ratio [182].

Implicancies in chemotherapy

In regard to chemotherapy or combined radiochemotherapy, toxicity rates still represent a recurrent issue to be solved, causing treatment interruptions in detriment of the expected oncological outcomes. A Cochrane systematic review analysed the results of 4 different studies who compared chemotherapy alone against chemotherapy plus traditional Chinese herbal medicine as cytoprotector. With 342 included subjects in total, and although a low-quality level was observed amongst the trials and no robust evidence could be obtained, the collected data points towards an improvement in immunocompetent cell stimulation and side effect decrease. Besides this, no toxic effect was associated to plant usage [183]. This hypothesis-generating conclusion should be considered baseline for further research with adequate methodology.

The willingness of natural medicine utilisation in certain regions ought to be of the oncology practitioners’ knowledge [184, 185]. Due to the wide spectrum and availability of natural products and lack of knowledge dissemination in terms of potential adverse events, caution should be taken while prescribing or delivering treatment. This is supported by an analysis comparing drug- (DDI) and herb-drug (HDI) interactions in cancer care. In these 149 patient cohorts, 36 clinically relevant DDI in 26 patients (17.4 %) and 122 HDI in 84 patients (56.4 %) were detected [186]. The importance of acknowledging the patient’s treatment desires lies in predicting and preventing potential harmful interactions combined with the indicated treatment. Besides, an important number of patients (~ 58 %) tend to hide this information from their treating physicians, which may also increase the risk of developing adverse events [187].

Different mechanisms have been described for explaining potential undesired interactions. The interference in P450 isozyme metabolism or drug transporter P-glycoprotein function due to consumption of garlic (Allium sativum), Ginko biloba, Echinacea purpurea, ginseng (Panax ginseng), amongst others, has been already mentioned in the literature as potential triggers for hepatic toxicity and reduced anticancer therapy effects [164, 188].

In contrast and reported by two randomised studies, higher seric concentrations of selenium and vitamin E have shown to improve hemathologic toxicity and neuropathy, respectively, in the setting of cisplating administration [189, 190].

Therapeutic and preventive ratio enhancement

Evidence from different publications, including one systematic review of 49 human studies, have highlighted the non-interfering profile of natural compounds with radiotherapy, such as beta-carotene, vitamins A, B, E, selenium, amongst others. Moreover, a lower rate of secondary effects enhanced tumouricidal action, and even potentially survival benefit [178, 182, 191].

Although widely studied in pre-clinical trials, no strong evidence in human subjects has been collected to date, in to classify phytochemicals usage and dosing in a defined clinical scenario. The example of breast cancer patients has shown, mostly in vitro, different action levels regarding proliferation, apoptosis, and metastasis, for specific compounds. For instance, resveratrol has shown reducing negative features by acting on estrogen receptors (ER), EFGR/PI3K, and ERK1/2 pathways. Additionally, the activity of other phytochemicals, like lignans or curcumin, inhibiting the HER-2 pathway, might be as well of benefit for specific case scenarios [192]. Clinical evidence extracted from other compound usage experience (isoflavones) opens a new path for further research. As it has been reported, a seemly lower rate of breast cancer has been related to its consumption in some Asian countries [193]. In addition, a prospective Spanish trial demonstrated the protective effect of the Mediterranean diet against breast cancer development [194, 195]. Caution while interpreting these publications is suggested, as they might incur in selection bias.

New approaches will be developed in the upcoming years with further vegetal species under the scope. Initial reports of antitumoural activity of Banisteriopsis caapi, for example, through various hypotetical molecular pathways, such as N,N-dimethyltryptamine in the intracellular sigma-1 receptors, and the activity of harmine, tetrahydroharmine, and harmaline, are generating great expectations to delucidate their potential contribution in cancer care [196]. Other studies currently undergoing in various institutions, to demonstrate the value of different phytochemicals for specific sites, are eagerly awaited to increase the oncologists’ therapeutical arsenal.

Chemoprevention exemplified for individual stages of cancer’s risk, development, and progression

As it was detailed above, several plant natural substances demonstrate genoprotective effects by complex antioxidant and detoxification activities, neutralisation of carcinogens, and DNA repair promotion. On the other hand, cytotoxic and genotoxic effects of plants and extracts have been demonstrated towards quickly proliferating tumour cells discriminating them against physiologic tissue [197, 198]. Below paragraphs illustrate clinically relevant effects applicable to

  • general cancer prevention

  • pre-cancerous lesions—individualised cancer prevention

  • selective cytotoxic effects against malignancies

  • circulating tumour cells and metastatic disease—mitigating strategies

  • phytochemical supplement in optimal palliative care setting

as exemplified specifically for colon carcinomas.

General colon cancer prevention in the population

Multi-factorial stress conditions leading to the excessive production of ROS are well-acknowledged to cause cancer predisposition as reported for hepatocellular carcinoma, glioma, malignancies of the blood, breast, colorectum, esophagus, kidney, lung, mouth, ovary, pancreas, prostate, and stomach [199]. To this end, the risk of developing malignancies is associated with the dose as well as timing of the exposure [200]. Consequently, individualised predictive approach is essential to make the primary prevention targeted and cost-effective [201, 202].

One of the most ubiquitous stress factors is an imbalanced and/or unhealthy diet increasing the general predisposition to colon cancer [203]. Specifically, so-called Western Diet Pattern is characterised by high intake of processed meat, red meat, or high-fat dairy products [204] being associated with an increased risk of colon cancer [167, 168]. In contrast, the Mediterranean diet pattern based on fruits and vegetables rich in various phytochemicals shows chemopreventive anticancer effects mediated via complex antioxidant, detoxification, and free radical scavenging activities [205, 206]. Unfortunately, people at high risk, due to genetic (inborn family) predisposition to colon cancer are not sufficiently responsing to a dietary prevention [207]. Consequently, supplementary protective measures are currently under extensive consideration such as improved microbiome setup as well as probiotics and nanoparticles with prebiotic properties supportive for immune system and applied depending on the individual predisposition and personalised patient profile [208, 209].

Pre-cancerous lesions and malignant cell transformation

Pre-cancerous colon lesions, such as polyps, ulcers, erosions, vascular lesions, mass, and nodules, are considered prestages of the colon cancer development [210]. Early diagnosis of multiple adenoma, a precursor to colorectal cancer, followed by application of plant natural substances may be highly protective reducing the overall risk of cancer development [174]. For example, Lynch syndrome patients, who are predisposed to various cancers including colorectal carcinomas and suffering from insufficient DNA repair capacity, demonstrate reduced inflammation and overall cancer risks by intake of nutritional Nrf2 activators such as phytochemicals (sulforaphane, curcumin, quercetin, resveratrol, and EGCG) [211]. Further, progression of neoplastic lesions into colon cancer is suppressed by Salvia officinalis tea via its chemopreventive effects [118]. To this end, the transformation of neoplastic lesions into malignant cells and anticancer effects by phytochemicals might be highly selective by killing rapidly proliferating cells [212]. Specifically, Premna odorata leaves, P. odorata bark hexane fractions and Artocarpus camansi leaves were found to be highly cytotoxic against HCT116 human colon cancer cell line, with P. odorata bark hexane extract demonstrating high selectivity/cytotoxic index [213]. Similar effects have been demonstrated also for several cancer types: triterpenoids, oleanolic acid 3-acetate, and betulinic acid, isolated from dichloromethane extracts of Clerodendrum indicum and Clerodendrum villosum, revealed moderate to strong cytotoxicity to colorectal adenocarcinoma (SW620), bronchogenic carcinoma (ChaGo-K-1), hepatocellular carcinoma (HepG2), gastric carcinoma (KATO-III), and ductal carcinoma (BT-474) cancer cell lines [214].

Cytotoxic effects to suppress circulating tumour cells and metastatic disease

Some plants via their content compounds exhibit selective cytotoxic effects against circulating tumour cells and metastatic potential. Specifically, apigenin, which can be detected in many vegetables and herbal spices, is capable to inhibit epithelial-mesenchymal transition (EMT) of human colon cancer cells that plays an essential role in the cancer metastasis progression [215]. Similarly, natural polyphenol calebin A, a component of turmeric, evidently suppresses proliferation, invasion, and metastasis spread by human colorectal cancer cells [216]. Considering corresponding molecular mechanisms, phytochemicals are capable to perturb signalling pathways associated with the cancer progression. Further clinical studies are needed to understand in more detail how patients can be best stratified for anticancer and anti-metastatic medication by well selected plants and phytochemicals.

Plant and phytochemical supplement in optimal palliative care setting

The concept of palliative care provided to cancer patients is currently evolving from just end of life care and relieve suffering to include all aspects of cancer survivorship. The new challenging concept needs to thoroughly consider diet and nutrition which positively impact individual outcomes by affecting cancer recurrence and progression. To this end, clear evidence is provided that herbs and their constituent phytochemicals may be biologic response modifiers that could increase cancer control within palliative care [217]. Moreover, herb and dietary supplements are the most popular complementary and alternative medicine modality used by cancer patients. How much they are supportive and whether they may interfere with the efficacy and safety of conventional medicines remains to be further investigated [218].

Concluding remarks, expert recommendations and outlook

Natural substances represent an attractive strategy for cancer primary and secondary prevention [219,220,221]. Preclinical cancer research demonstrated potent genoprotective properties of natural plant substances in non-cancer models [103, 106, 124,125,126, 222]. Regarding clinical research, the uses of germ-line, familiar, or high-risk cohorts are associated with more power over a shorter time frame of the clinical trials when compared with subjects with average risk [223]. Identification of high-risk individuals who would benefit from targeted preventive strategies described above is an essential measure which may significantly reduce cancer incidence in the population. Multi-level diagnostics, including phenotyping and genotyping, is considered an optimal tool for prediction and targeted prevention [224, 225]. Further, multiomics plays a key role in cancer predictive and early diagnostics [226].

By evidence, administration of plant natural substances and/or diet supplements slows down or even inhibits carcinogenesis in healthy and high-risk individuals. Plant natural substances and phytochemicals decrease oxidative damage to biologically important molecules, increase antioxidant status and scavenging capacity against excessive ROS production; thereby, cells are better protected against carcinogen-induced DNA damage and both—detoxification and DNA repair pathways—are stimulated [18, 24, 26, 149,150,151,152,153,154,155,156,157,158]. However, clinically relevant recommendations in this regards are still underrepresented. Obviously clinical trials focused on individualised patient profiles and consequent patient stratification would be useful to bring the preclinical discoveries in the field to the daily clinical practice benefiting the patients and healthcare as the whole. To this end, since a large part of cancers is considered preventable, particularly primary chemoprevention may offer plausible solutions to address the global problem of increasing cancer incidence [227, 228]. In general, innovative approaches by preventive medicine provide new opportunities for clinical oncology [193]. 3PM strategies are considered being particularly important to advance the overall cancer management making the services cost-effective [194]. As detailed above, chemopreventive strategies play an important role in the context of 3P medicine [229]. However, further research for determining active compounds and dosing selection is urgently warranted to effectively promote their clinical implementation in terms of primary and secondary chemoprevention as well as cancer management as a whole [230,231,232].


  1. 1.

    Mahady G. Medicinal plants for the prevention and treatment of bacterial infections. Curr Pharm Des. 2005;11:2405–27.

    CAS  Article  PubMed  Google Scholar 

  2. 2.

    Kubatka, Uramova, Kello, Kajo, Samec, Jasek, et al. Mojzis; Adamkov; et al. Anticancer activities of Thymus vulgaris L. in experimental breast carcinoma in vivo and in vitro. Int J Mol Sci. 2019;20:1749.

    CAS  Article  PubMed Central  Google Scholar 

  3. 3.

    Zhang Y-J, Gan R-Y, Li S, Zhou Y, Li A-N, Xu D-P, et al. Antioxidant phytochemicals for the prevention and treatment of chronic diseases. Mol Basel Switz. 2015;20:21138–56.

    CAS  Article  Google Scholar 

  4. 4.

    Zhu F, Du B, Xu B. Anti-inflammatory effects of phytochemicals from fruits, vegetables, and food legumes: a review. Crit Rev Food Sci Nutr. 2018;58:1260–70.

    CAS  Article  PubMed  Google Scholar 

  5. 5.

    Suurbaar J, Mosobil R, Donkor A-M. Antibacterial and antifungal activities and phytochemical profile of leaf extract from different extractants of Ricinus communis against selected pathogens. BMC Res Notes. 2017;10.

  6. 6.

    Wintola O, Afolayan A. The antibacterial, phytochemicals and antioxidants evaluation of the root extracts of Hydnora africanaThunb. used as antidysenteric in Eastern Cape Province, South Africa. BMC Complement. Altern Med. 2015;15.

  7. 7.

    Kubatka P, Uramova S, Kello M, Kajo K, Kruzliak P, Mojzis J, et al. Antineoplastic effects of clove buds (Syzygium aromaticum L.) in the model of breast carcinoma. J Cell Mo. Med. 2017;21:2837–51.

    CAS  Article  Google Scholar 

  8. 8.

    Kubatka P, Kello M, Kajo K, Kruzliak P, Výbohová D, Mojžiš J, et al. Oregano demonstrates distinct tumour-suppressive effects in the breast carcinoma model. Eur J Nutr. 2017;56:1303–16.

    CAS  Article  PubMed  Google Scholar 

  9. 9.

    Alam, M.N.; Almoyad, M.; Huq, F. Polyphenols in colorectal cancer: current state of knowledge including clinical trials and molecular mechanism of action Available online: (accessed on Feb 7, 2020).

  10. 10.

    Khan MA, Tania M, Fu S, Fu J. Thymoquinone, as an anticancer molecule: from basic research to clinical investigation. Oncotarget. 2017;8:51907–19.

    Article  Google Scholar 

  11. 11.

    Hosseini A, Ghorbani A. Cancer therapy with phytochemicals: evidence from clinical studies. Avicenna J Phytomed. 2015;5:84–97.

    CAS  PubMed  PubMed Central  Google Scholar 

  12. 12.

    Barabadi H, Najafi M, Samadian H, Azarnezhad A, Vahidi H, Mahjoub MA, et al. A systematic review of the genotoxicity and antigenotoxicity of biologically synthesized metallic nanomaterials: are green nanoparticles safe enough for clinical marketing? Medicina (Mex.). 2019;55:439.

    Article  Google Scholar 

  13. 13.

    Chakravarthi BVSK, Nepal S, Varambally S. Genomic and epigenomic alterations in cancer. Am J Pathol. 2016;186:1724–35.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  14. 14.

    Szeto YT, Wong SCY, Wong JWM, Kalle W, Pak SC. In vitro antioxidation activity and genoprotective effect of selected Chinese medicinal herbs. Am J Chin Med. 2011;39:827–38.

    Article  PubMed  Google Scholar 

  15. 15.

    Basu AK, Damage DNA. Mutagenesis and cancer. Int J Mol Sci. 2018:19.

  16. 16.

    Sankpal UT, Pius H, Khan M, Shukoor MI, Maliakal P, Lee CM, et al. Environmental factors in causing human cancers: emphasis on tumorigenesis. Tumour Biol J Int Soc Oncodevelopmental Biol Med. 2012;33:1265–74.

    CAS  Article  Google Scholar 

  17. 17.

    Grech G, Zhan X, Yoo BC, Bubnov R, Hagan S, Danesi R, et al. EPMA position paper in cancer: current overview and future perspectives. EPMA J. 2015;6:9.

    Article  PubMed  PubMed Central  Google Scholar 

  18. 18.

    Collins AR, Harrington V, Drew J, Melvin R. Nutritional modulation of DNA repair in a human intervention study. Carcinogenesis. 2003;24:511–5.

    CAS  Article  PubMed  Google Scholar 

  19. 19.

    Das S, Das J, Samadder A, Paul A, Khuda-Bukhsh AR. Efficacy of PLGA-loaded apigenin nanoparticles in Benzo[a]pyrene and ultraviolet-B induced skin cancer of mice: MItochondria mediated apoptotic signalling cascades. Food Chem Toxicol. 2013;62:670–80.

    CAS  Article  PubMed  Google Scholar 

  20. 20.

    Faust D, Nikolova T, Wätjen W, Kaina B, Dietrich C. The Brassica-derived phytochemical indolo[3,2-b]carbazole protects against oxidative DNA damage by aryl hydrocarbon receptor activation. Arch Toxicol. 2017;91:967–82.

    CAS  Article  PubMed  Google Scholar 

  21. 21.

    Liu W, Wang G, Palovcak A, Li Y, Hao S, Liu Z-J, et al. Impeding the single-strand annealing pathway of DNA double-strand break repair by withaferin A-mediated FANCA degradation. DNA Repair. 2019;77:10–7.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  22. 22.

    Prasad KS, Selvaraj K. Biogenic synthesis of selenium nanoparticles and their effect on As(III)-induced toxicity on human lymphocytes. Biol Trace Elem Res. 2014;157:275–83.

    CAS  Article  PubMed  Google Scholar 

  23. 23.

    Pussila M, Törönen P, Einarsdottir E, Katayama S, Krjutškov K, Holm L, et al. Mlh1 deficiency in normal mouse colon mucosa associates with chromosomally unstable colon cancer. Carcinogenesis. 2018;39:788–97.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  24. 24.

    Salvini S, Sera F, Caruso D, Giovannelli L, Visioli F, Saieva C, et al. Daily consumption of a high-phenol extra-virgin olive oil reduces oxidative DNA damage in postmenopausal women. Br J Nutr. 2006;95:742–51.

    CAS  Article  PubMed  Google Scholar 

  25. 25.

    Vijaya PP, Rekha B, Mathew AT, Syed Ali M, Yogananth N, Anuradha V, et al. Antigenotoxic effect of green-synthesised silver nanoparticles from Ocimum sanctum leaf extract against cyclophosphamide induced genotoxicity in human lymphocytes—in vitro. Appl Nanosci. 2014;4:415–20.

    CAS  Article  Google Scholar 

  26. 26.

    Zhao X, Aldini G, Johnson EJ, Rasmussen H, Kraemer K, Woolf H, et al. Modification of lymphocyte DNA damage by carotenoid supplementation in postmenopausal women. Am J Clin Nutr. 2006;83:163–9.

    CAS  Article  PubMed  Google Scholar 

  27. 27.

    Weitzman MD, Lilley CE, Chaurushiya MS. Genomes in conflict: maintaining genome integrity during virus infection. Annu Rev Microbiol. 2010;64:61–81.

    CAS  Article  PubMed  Google Scholar 

  28. 28.

    Rajendran P, Ho E, Williams DE, Dashwood RH. Dietary phytochemicals, HDAC inhibition, and DNA damage/repair defects in cancer cells. Clin Epigenetics. 2011;3:4.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  29. 29.

    Moloney JN, Cotter TG. ROS signalling in the biology of cancer. Semin Cell Dev Biol. 2018;80:50–64.

    CAS  Article  PubMed  Google Scholar 

  30. 30.

    Wajed SA, Laird PW, DeMeester TR. DNA methylation: an alternative pathway to cancer. Ann Surg. 2001;234:10–20.

    CAS  Article  Google Scholar 

  31. 31.

    Valverde M, Lozano-Salgado J, Fortini P, Rodriguez-Sastre MA, Rojas E, Dogliotti E. Hydrogen peroxide-induced DNA damage and repair through the differentiation of human adipose-derived mesenchymal stem cells. Stem Cells Int. 2018;2018.

  32. 32.

    Plazar J, Žegura B, Lah TT, Filipič M. Protective effects of xanthohumol against the genotoxicity of benzo(a)pyrene (BaP), 2-amino-3-methylimidazo[4,5-f]quinoline (IQ) and tert-butyl hydroperoxide (t-BOOH) in HepG2 human hepatoma cells. Mutat Res Toxicol Environ Mutagen. 2007;632:1–8.

    CAS  Article  Google Scholar 

  33. 33.

    Valavanidis A, Vlachogianni T, Fiotakis C. 8-hydroxy-2’ -deoxyguanosine (8-OHdG): a critical biomarker of oxidative stress and carcinogenesis. J Environ Sci Health Part C Environ Carcinog Ecotoxicol Rev. 2009;27:120–39.

    CAS  Article  Google Scholar 

  34. 34.

    Cadet J, Douki T. Formation of UV-induced DNA damage contributing to skin cancer development. Photochem Photobiol Sci. 2018;17:1816–41.

    CAS  Article  PubMed  Google Scholar 

  35. 35.

    Schreier WJ, Schrader TE, Koller FO, Gilch P, Crespo-Hernández CE, Swaminathan VN, et al. Thymine dimerization in DNA is an ultrafast photoreaction. Science. 2007;315:625–9.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  36. 36.

    Barnes JL, Zubair M, John K, Poirier MC, Martin FL. Carcinogens and DNA damage. Biochem Soc Trans. 2018;46:1213–24.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  37. 37.

    Liskova A, Stefanicka P, Samec M, Smejkal K, Zubor P, Bielik T, et al. Dietary phytochemicals as the potential protectors against carcinogenesis and their role in cancer chemoprevention. Clin Exp Med. 2020.

  38. 38.

    Khan AQ, Travers JB, Kemp MG. Roles of UVA radiation and DNA damage responses in melanoma pathogenesis. Environ Mol Mutagen. 2018;59:438–60.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  39. 39.

    Malloy KD, Holman MA, Mitchell D, Detrich HW. Solar UVB-induced DNA damage and photoenzymatic DNA repair in antarctic zooplankton. Proc Natl Acad Sci U S A. 1997;94:1258–63.

    CAS  Article  Google Scholar 

  40. 40.

    Borrego-Soto G, Ortiz-López R, Rojas-Martínez A. Ionizing radiation-induced DNA injury and damage detection in patients with breast cancer. Genet Mol Biol. 2015;38:420–32.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  41. 41.

    Revel A, Raanani H, Younglai E, Xu J, Rogers I, Han R, et al. Resveratrol, a natural aryl hydrocarbon receptor antagonist, protects lung from DNA damage and apoptosis caused by benzo[a]pyrene. J Appl Toxicol. 2003;23:255–61.

    CAS  Article  PubMed  Google Scholar 

  42. 42.

    Verbinnen I, Boens S, Ferreira M, Szekér K, Van Wijk L, Van Eynde A, et al. Enhanced DNA-repair capacity and resistance to chemically induced carcinogenesis upon deletion of the phosphatase regulator NIPP1. Oncogenesis. 2020;9:30.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  43. 43.

    Nerurkar PV, Schut HA, Anderson LM, Riggs CW, Snyderwine EG, Thorgeirsson SS, et al. DNA adducts of 2-amino-3-methylimidazo[4,5-f]quinoline (IQ) in colon, bladder, and kidney of congenic mice differing in Ah responsiveness and N-acetyltransferase genotype. Cancer Res. 1995;55:3043–9.

    CAS  PubMed  Google Scholar 

  44. 44.

    Møller P, Wallin H, Vogel U, Autrup H, Risom L, Hald MT, et al. Mutagenicity of 2-amino-3-methylimidazo[4,5-f]quinoline in colon and liver of Big Blue rats: role of DNA adducts, strand breaks, DNA repair and oxidative stress. Carcinogenesis. 2002;23:1379–85.

    Article  PubMed  Google Scholar 

  45. 45.

    Ooka M, Takazawa H, Takeda S, Hirota K. Cytotoxic and genotoxic profiles of benzo[a]pyrene and N-nitrosodimethylamine demonstrated using DNA repair deficient DT40 cells with metabolic activation. Chemosphere. 1901–1907;2016:144.

    CAS  Article  Google Scholar 

  46. 46.

    Cruet-Hennequart S, Prendergast ÁM, Shaw G, Barry FP, Carty MP. Doxorubicin induces the DNA damage response in cultured human mesenchymal stem cells. Int J Hematol. 2012;96:649–56.

    CAS  Article  PubMed  Google Scholar 

  47. 47.

    Dusre L, Covey JM, Collins C, Sinha BK. DNA damage, cytotoxicity and free radical formation by mitomycin C in human cells. Chem Biol Interact. 1989;71:63–78.

    CAS  Article  PubMed  Google Scholar 

  48. 48.

    Hinrichs B, Zahid M, Saeed M, Ali MF, Cavalieri EL, Rogan EG. Formation of diethylstilbestrol–DNA adducts in human breast epithelial cells and inhibition by resveratrol. J Steroid Biochem Mol Biol. 2011;127:276–81.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  49. 49.

    Goodenow D, Emmanuel F, Berman C, Sahyouni M, Richardson C. Bioflavonoids cause DNA double-strand breaks and chromosomal translocations through topoisomerase II-dependent and -independent mechanisms. Mutat Res. 2020;849:503144.

    CAS  Article  PubMed  Google Scholar 

  50. 50.

    Shrivastav N, Li D, Essigmann JM. Chemical biology of mutagenesis and DNA repair: cellular responses to DNA alkylation. Carcinogenesis. 2010;31:59–70.

    CAS  Article  PubMed  Google Scholar 

  51. 51.

    Koryllou A, Patrinou-Georgoula M, Dimozi A, Kyrtopoulos SA, Pletsa V. Investigation of cell death induced by N-methyl-N-nitrosourea in cell lines of human origin and implication of RNA binding protein alterations. Anticancer Res. 2011;31:4291–9.

    CAS  PubMed  Google Scholar 

  52. 52.

    Schwitalla S, Ziegler PK, Horst D, Becker V, Kerle I, Begus-Nahrmann Y, et al. Loss of p53 in enterocytes generates an inflammatory microenvironment enabling invasion and lymph node metastasis of carcinogen-induced colorectal tumors. Cancer Cell. 2013;23:93–106.

    CAS  Article  PubMed  Google Scholar 

  53. 53.

    Feng W-H, Xue KS, Tang L, Williams PL, Wang J-S. Aflatoxin B1-induced developmental and dna damage in caenorhabditis elegans. Toxins. 2016;9.

  54. 54.

    Bedard LL, Massey TE. Aflatoxin B1-induced DNA damage and its repair. Cancer Lett. 2006;241:174–83.

    CAS  Article  PubMed  Google Scholar 

  55. 55.

    Muenyi CS, Ljungman M, States JC. Arsenic disruption of dna damage responses—potential role in carcinogenesis and chemotherapy. Biomolecules. 2015;5:2184–93.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  56. 56.

    Valko M, Rhodes CJ, Moncol J, Izakovic M, Mazur M. Free radicals, metals and antioxidants in oxidative stress-induced cancer. Chem Biol Interact. 2006;160:1–40.

    CAS  Article  PubMed  Google Scholar 

  57. 57.

    Prasanth MI, Sivamaruthi BS, Chaiyasut C, Tencomnao T. A review of the role of green tea (Camellia sinensis) in antiphotoaging, stress resistance, neuroprotection, and autophagy. Nutrients. 2019;11.

  58. 58.

    Bernatoniene J, Kopustinskiene DM. The role of catechins in cellular responses to oxidative stress. Mol J Synth Chem Nat Prod Chem. 2018:23.

  59. 59.

    Vallejo MJ, Salazar L, Grijalva M. Oxidative stress modulation and ROS-mediated toxicity in cancer: a review on in vitro models for plant-derived compounds. Oxidative Med Cell Longev. 2017;2017:4586068.

    CAS  Article  Google Scholar 

  60. 60.

    Trachootham D, Alexandre J, Huang P. Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach? Nat Rev Drug Discov. 2009;8:579–91.

    CAS  Article  PubMed  Google Scholar 

  61. 61.

    Shah MH, Liu G-S, Thompson EW, Dusting GJ, Peshavariya HM. Differential effects of superoxide dismutase and superoxide dismutase/catalase mimetics on human breast cancer cells. Breast Cancer Res Treat. 2015;150:523–34.

    CAS  Article  PubMed  Google Scholar 

  62. 62.

    Li R, Jia Z, Zhu H. Regulation of Nrf2 signaling. React Oxyg Species Apex NC. 2019;8:312–22.

    Google Scholar 

  63. 63.

    Nguyen T, Nioi P, Pickett CB. The Nrf2-antioxidant response element signaling pathway and its activation by oxidative stress. J Biol Chem. 2009;284:13291–5.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  64. 64.

    Köhle C, Bock KW. Activation of coupled Ah receptor and Nrf2 gene batteries by dietary phytochemicals in relation to chemoprevention. Biochem Pharmacol. 2006;72:795–805.

    CAS  Article  PubMed  Google Scholar 

  65. 65.

    Niture SK, Khatri R, Jaiswal AK. Regulation of Nrf2–an update. Free Radic Biol Med. 2014;66.

  66. 66.

    Powell JB, Ghotbaddini M. Cancer-promoting and inhibiting effects of dietary compounds: role of the aryl hydrocarbon receptor (AhR). Biochem Pharmacol Open Access. 2014;3.

  67. 67.

    Guo J, Xu Y, Ji W, Song L, Dai C, Zhan L. Effects of exposure to benzo[a]pyrene on metastasis of breast cancer are mediated through ROS-ERK-MMP9 axis signaling. Toxicol Lett. 2015;234:201–10.

    CAS  Article  PubMed  Google Scholar 

  68. 68.

    Hardonnière K, Saunier E, Lemarié A, Fernier M, Gallais I, Héliès-Toussaint C, et al. The environmental carcinogen benzo[a]pyrene induces a Warburg-like metabolic reprogramming dependent on NHE1 and associated with cell survival. Sci Rep. 2016;6:30776.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  69. 69.

    Wei Y, Zhao L, He W, Yang J, Geng C, Chen Y, et al. Benzo[a]pyrene promotes gastric cancer cell proliferation and metastasis likely through the Aryl hydrocarbon receptor and ERK-dependent induction of MMP9 and c-myc. Int J Oncol. 2016;49:2055–63.

    CAS  Article  PubMed  Google Scholar 

  70. 70.

    Rahal A, Kumar A, Singh V, Yadav B, Tiwari R, Chakraborty S, et al. Oxidative stress, prooxidants, and antioxidants: the interplay. Biomed Res Int. 2014;2014.

  71. 71.

    Eghbaliferiz S, Iranshahi M. Prooxidant activity of polyphenols, flavonoids, anthocyanins and carotenoids: updated review of mechanisms and catalyzing metals. Phytother Res PTR. 2016;30:1379–91.

    CAS  Article  PubMed  Google Scholar 

  72. 72.

    Zheng L-F, Dai F, Zhou B, Yang L, Liu Z-L. Prooxidant activity of hydroxycinnamic acids on DNA damage in the presence of Cu(II) ions: mechanism and structure-activity relationship. Food Chem Toxicol Int J Publ Br Ind Biol Res Assoc. 2008;46:149–56.

    CAS  Article  Google Scholar 

  73. 73.

    Jomová K, Hudecova L, Lauro P, Simunkova M, Alwasel SH, Alhazza IM, et al. A switch between antioxidant and prooxidant properties of the phenolic compounds myricetin, morin, 3′,4′-dihydroxyflavone, taxifolin and 4-hydroxy-coumarin in the presence of copper(II) ions: a spectroscopic, absorption titration and DNA damage study. Molecules. 2019;24.

  74. 74.

    Chen Q, Espey MG, Sun AY, Pooput C, Kirk KL, Krishna MC, et al. Pharmacologic doses of ascorbate act as a prooxidant and decrease growth of aggressive tumor xenografts in mice. Proc Natl Acad Sci U S A. 2008;105:11105–9.

    Article  PubMed  PubMed Central  Google Scholar 

  75. 75.

    Stafford WC, Peng X, Olofsson MH, Zhang X, Luci DK, Lu L, et al. Irreversible inhibition of cytosolic thioredoxin reductase 1 as a mechanistic basis for anticancer therapy. Sci Transl Med. 2018;10.

  76. 76.

    Konaté MM, Antony S, Doroshow JH. Inhibiting the activity of NADPH oxidase in cancer. Antioxid Redox Signal. 2020.

  77. 77.

    Kirlin WG, Cai J, DeLong MJ, Patten EJ, Jones DP. Dietary compounds that induce cancer preventive phase 2 enzymes activate apoptosis at comparable doses in HT29 colon carcinoma cells. J Nutr. 1999;129:1827–35.

    CAS  Article  PubMed  Google Scholar 

  78. 78.

    Jana S, Mandlekar S. Role of phase II drug metabolizing enzymes in cancer chemoprevention. Curr Drug Metab. 2009;10:595–616.

    CAS  Article  PubMed  Google Scholar 

  79. 79.

    Lindros KO. Zonation of cytochrome P450 expression, drug metabolism and toxicity in liver. Gen Pharmacol Vasc Syst. 1997;28:191–6.

    CAS  Article  Google Scholar 

  80. 80.

    Kaur G, Gupta SK, Singh P, Ali V, Kumar V, Verma M. Drug-metabolizing enzymes: role in drug resistance in cancer. Clin Transl Oncol Off Publ Fed Span Oncol Soc Natl Cancer Inst Mex. 2020.

  81. 81.

    Talalay P. Chemoprotection against cancer by induction of phase 2 enzymes. BioFactors Oxf Engl. 2000;12:5–11.

    CAS  Article  Google Scholar 

  82. 82.

    Dusinska M, Staruchova M, Horska A, Smolkova B, Collins A, Bonassi S, et al. Are glutathione S transferases involved in DNA damage signalling? Interactions with DNA damage and repair revealed from molecular epidemiology studies. Mutat Res. 2012;736:130–7.

    CAS  Article  PubMed  Google Scholar 

  83. 83.

    Furgason JM, Bahassi EM. Targeting DNA repair mechanisms in cancer. Pharmacol Ther. 2013;137:298–308.

    CAS  Article  PubMed  Google Scholar 

  84. 84.

    Mitra S, Boldogh I, Izumi T, Hazra TK. Complexities of the DNA base excision repair pathway for repair of oxidative DNA damage. Environ Mol Mutagen. 2001;38:180–90.

    CAS  Article  Google Scholar 

  85. 85.

    Mitra S, Hazra TK, Roy R, Ikeda S, Biswas T, Lock J, et al. Complexities of DNA base excision repair in mammalian cells. Mol Cell. 1997;7:305–12.

    CAS  Google Scholar 

  86. 86.

    Friedberg EC. How nucleotide excision repair protects against cancer. Nat Rev Cancer. 2001;1:22–33.

    CAS  Article  PubMed  Google Scholar 

  87. 87.

    Pimpley MR, Foley ML, Latimer JJ. New perspectives on unscheduled DNA synthesis: functional assay for global genomic DNA nucleotide excision repair. Methods Mol Biol Clifton NJ. 2020;2102:483–507.

    Article  Google Scholar 

  88. 88.

    Harfe BD, Jinks-Robertson S. DNA mismatch repair and genetic instability. Annu Rev Genet. 2000;34:359–99.

    CAS  Article  PubMed  Google Scholar 

  89. 89.

    Zhang D, Tang B, Xie X, Xiao Y-F, Yang S-M, Zhang J-W. The interplay between DNA repair and autophagy in cancer therapy. Cancer Biol Ther. 2015;16:1005–13.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  90. 90.

    Jackson SP. Sensing and repairing DNA double-strand breaks. Carcinogenesis. 2002;23:687–96.

    CAS  Article  PubMed  Google Scholar 

  91. 91.

    Ceccaldi R, Rondinelli B, D’Andrea AD. Repair pathway choices and consequences at the double-strand break. Trends Cell Biol. 2016;26:52–64.

    CAS  Article  PubMed  Google Scholar 

  92. 92.

    Lieber MR. The mechanism of double-strand DNA break repair by the nonhomologous DNA end-joining pathway. Annu Rev Biochem. 2010;79:181–211.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  93. 93.

    Her J, Bunting SF. How cells ensure correct repair of DNA double-strand breaks. J Biol Chem. 2018;293:10502–11.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  94. 94.

    Alan D, D’Andrea MD. The Fanconi anemia and breast cancer susceptibility pathways. N Engl J Med. 2010;362:1909–19.

    Article  PubMed Central  Google Scholar 

  95. 95.

    Aparicio T, Baer R, Gautier J. DNA double-strand break repair pathway choice and cancer. DNA Repair. 2014;19:169–75.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  96. 96.

    Kapinova A, Kubatka P, Liskova A, Baranenko D, Kruzliak P, Matta M, et al. Controlling metastatic cancer: the role of phytochemicals in cell signaling. J Cancer Res Clin Oncol. 2019;145:1087–109.

    CAS  Article  PubMed  Google Scholar 

  97. 97.

    Kapinova A, Stefanicka P, Kubatka P, Zubor P, Uramova S, Kello M, et al. Are plant-based functional foods better choice against cancer than single phytochemicals? A critical review of current breast cancer research. Biomed Pharmacother Biomedecine Pharmacother. 2017;96:1465–77.

    CAS  Article  Google Scholar 

  98. 98.

    Abotaleb M, Samuel S, Varghese E, Varghese S, Kubatka P, Liskova A, et al. Flavonoids in cancer and apoptosis. Cancers. 2018;11:28.

    CAS  Article  PubMed Central  Google Scholar 

  99. 99.

    Liskova A, Kubatka P, Samec M, Zubor P, Mlyncek M, Bielik T, et al. Dietary phytochemicals targeting cancer stem cells. Mol Basel Switz. 2019;24.

  100. 100.

    Abotaleb M, Liskova A, Kubatka P, Büsselberg D. Therapeutic potential of plant phenolic acids in the treatment of cancer. Biomolecules. 2020;10.

  101. 101.

    Chakraborty S, Roy M, Bhattacharya RK. Prevention and repair of DNA damage by selected phytochemicals as measured by single cell gel electrophoresis. J Environ Pathol Toxicol Oncol Off Organ Int Soc Environ Toxicol Cancer. 2004;23:215–26.

    CAS  Article  Google Scholar 

  102. 102.

    López-Romero D, Izquierdo-Vega JA, Morales-González JA, Madrigal-Bujaidar E, Chamorro-Cevallos G, Sánchez-Gutiérrez M, et al. Evidence of some natural products with antigenotoxic effects. Part 2: Plants, vegetables, and natural resin. Nutrients. 2018;10:1954.

    CAS  Article  PubMed Central  Google Scholar 

  103. 103.

    Venancio VP, Marques MC, Almeida MR, Mariutti LRB, Souza VC d O, Barbosa F, et al. Chrysobalanus icaco L. fruits inhibit NADPH oxidase complex and protect DNA against doxorubicin-induced damage in Wistar male rats. J Toxicol Environ Health A. 2016;79:885–93.

    CAS  Article  PubMed  Google Scholar 

  104. 104.

    Jiang J, Xu H, Wang H, Zhang Y, Ya P, Yang C, et al. Protective effects of lemongrass essential oil against benzo(a)pyrene-induced oxidative stress and DNA damage in human embryonic lung fibroblast cells. Toxicol Mech Methods. 2017;27:121–7.

    CAS  Article  PubMed  Google Scholar 

  105. 105.

    Nicastro HL, Ross SA, Milner JA. Garlic and onions: their cancer prevention properties. Cancer Prev Res (Phila). 2015;8:181–9.

    CAS  Article  Google Scholar 

  106. 106.

    Fredotović Ž, Šprung M, Soldo B, Ljubenkov I, Budić-Leto I, Bilušić T, et al. Chemical Composition and biological activity of Allium cepa L. and Allium × cornutum (Clementi ex Visiani 1842) methanolic extracts. Mol J Synth Chem Nat Prod Chem. 2017:22.

  107. 107.

    Batool R, Khan MR, Majid M. Euphorbia dracunculoides L. abrogates carbon tetrachloride induced liver and DNA damage in rats. BMC Complement. Altern Med. 2017;17.

  108. 108.

    Iliemene UD, Atawodi SE-O. Preventive potential of dietary inclusion of Brachystegia eurycoma (Harms) seeds on N-methyl-N-nitrosourea-induced colon carcinogenesis in Wistar rats. J Ethnopharmacol. 2019;238:111858.

    CAS  Article  PubMed  Google Scholar 

  109. 109.

    Sehrawat A, Sultana S. Chemoprevention by Butea monosperma of hepatic carcinogenesis and oxidative damage in male wistar rats. 9.

  110. 110.

    Sehrawat A, Kumar V. Butein imparts free radical scavenging, anti-oxidative and pro- apoptotic properties in the flower extracts of Butea monosperma. 10.

  111. 111.

    Kaur V, Kumar M, Kumar A, Kaur S. Butea monosperma (Lam.) Taub. Bark fractions protect against free radicals and induce apoptosis in MCF-7 breast cancer cells via cell-cycle arrest and ROS-mediated pathway. Drug Chem Toxicol. 2018:1–11.

  112. 112.

    Del Pino-García R, Rivero-Pérez MD, González-SanJosé ML, Ortega-Heras M, García Lomillo J, Muñiz P. Chemopreventive potential of powdered red wine pomace seasonings against colorectal cancer in HT-29 Cells. J Agric Food Chem. 2017;65:66–73.

    CAS  Article  PubMed  Google Scholar 

  113. 113.

    Wang S, Cheng L, Liu Y, Wang J, Jiang W. Indole-3-Carbinol (I3C) and its major derivatives: their pharmacokinetics and important roles in hepatic protection. Curr Drug Metab. 2016;17:401–9.

    CAS  Article  PubMed  Google Scholar 

  114. 114.

    Kubatka P, Kello M, Kajo K, Kruzliak P, Výbohová D, Šmejkal K, et al. Young barley indicates antitumor effects in experimental breast cancer in vivo and in vitro. Nutr Cancer. 2016;68:611–21.

    CAS  Article  PubMed  Google Scholar 

  115. 115.

    Kubatka P, Kapinová A, Kello M, Kruzliak P, Kajo K, Výbohová D, et al. Fruit peel polyphenols demonstrate substantial anti-tumour effects in the model of breast cancer. Eur J Nutr. 2016;55:955–65.

    CAS  Article  PubMed  Google Scholar 

  116. 116.

    Kubatka P, Kello M, Kajo K, Samec M, Jasek K, Vybohova D, et al. Chemopreventive and Therapeutic efficacy of Cinnamomum zeylanicum L. bark in experimental breast carcinoma: mechanistic in vivo and in vitro analyses. Molecules. 2020;25:1399.

    CAS  Article  PubMed Central  Google Scholar 

  117. 117.

    Ganie SA, Ali Dar T, Zargar S, Bhat AH, Dar KB, Masood A, et al. Crataegus songarica methanolic extract accelerates enzymatic status in kidney and heart tissue damage in albino rats and its in vitro cytotoxic activity. Pharm Biol. 2016;54:1246–54.

    CAS  Article  PubMed  Google Scholar 

  118. 118.

    Pedro DFN, Ramos AA, Lima CF, Baltazar F, Pereira-Wilson C. Colon cancer chemoprevention by sage tea drinking: decreased DNA damage and cell proliferation. Phytother Res PTR. 2016;30:298–305.

    CAS  Article  PubMed  Google Scholar 

  119. 119.

    Özkan A, Erdoğan A. Evaluation of cytotoxic, membrane, and DNA damaging effects of Thymus revolutus Célak essential oil on different cancer cells. Turk J Med Sci. 2017;47:702–14.

    CAS  Article  PubMed  Google Scholar 

  120. 120.

    Chikara S, Mamidi S, Sreedasyam A, Chittem K, Pietrofesa R, Zuppa A, et al. Flaxseed consumption inhibits chemically-induced lung tumorigenesis and modulates expression of phase II enzymes and inflammatory cytokines in A/J mice. Cancer Prev Res (Phila). 2018;11:27–37.

    CAS  Article  Google Scholar 

  121. 121.

    Sharma R, Williams IS, Gatchie L, Sonawane VR, Chaudhuri B, Bharate SB. Furanoflavones pongapin and lanceolatin B blocks the cell cycle and induce senescence in CYP1A1-overexpressing breast cancer cells. Bioorg Med Chem. 2018;26:6076–86.

    CAS  Article  PubMed  Google Scholar 

  122. 122.

    Sm F, Sravanthi K, Debnath R, Neeraja K. Protective effect of ethanolic extract and its ethylacetate and n-butanol fractions of Sechium edule fruits against carbon tetrachloride induced hepatic injury in rats.; 2012.

  123. 123.

    Mouret S, Baudouin C, Charveron M, Favier A, Cadet J, Douki T. Cyclobutane pyrimidine dimers are predominant DNA lesions in whole human skin exposed to UVA radiation. Proc Natl Acad Sci U S A. 2006;103:13765–70.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  124. 124.

    Metral E, Rachidi W, Damour O, Demarne F, Bechetoille N. Long-term genoprotection effect of Sechium edule fruit extract against UVA irradiation in keratinocytes. Photochem Photobiol. 2018;94:343–50.

    CAS  Article  PubMed  Google Scholar 

  125. 125.

    Lightbourn AV, Thomas RD. Crude edible fig (Ficus carica) Leaf extract prevents diethylstilbestrol (DES)-induced DNA strand breaks in single-cell gel electrophoresis (SCGE)/comet assay: literature review and pilot study. J Bioequivalence Bioavailab. 2019;11:19–28.

    Article  PubMed  PubMed Central  Google Scholar 

  126. 126.

    Farooq A. Structural and functional diversity of estrogen receptor ligands. Curr Top Med Chem. 2015;15:1372–84.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  127. 127.

    Das S, Bisht SS. The bioactive and therapeutic potential of Hemidesmus indicus R. Br. (Indian Sarsaparilla) root. Phytother Res PTR. 2013;27:791–801.

    Article  PubMed  Google Scholar 

  128. 128.

    Turrini E, Calcabrini C, Tacchini M, Efferth T, Sacchetti G, Guerrini A, et al. In vitro study of the cytotoxic, cytostatic, and antigenotoxic profile of Hemidesmus indicus (L.) R.Br. (Apocynaceae) crude drug extract on T lymphoblastic cells. Toxins. 2018:10.

  129. 129.

    Wang S, Su R, Nie S, Sun M, Zhang J, Wu D, et al. Application of nanotechnology in improving bioavailability and bioactivity of diet-derived phytochemicals. J Nutr Biochem. 2014;25:363–76.

    CAS  Article  PubMed  Google Scholar 

  130. 130.

    Thiruvengadam M, Rajakumar G, Chung I-M. Nanotechnology: current uses and future applications in the food industry. 3 Biotech. 2018;8.

  131. 131.

    Samec M, Liskova A, Kubatka P, Uramova S, Zubor P, Samuel SM, et al. The role of dietary phytochemicals in the carcinogenesis via the modulation of miRNA expression. J Cancer Res Clin Oncol. 2019;145:1665–79.

    CAS  Article  PubMed  Google Scholar 

  132. 132.

    Samec M, Liskova A, Koklesova L, Mestanova V, Franekova M, Kassayova M, et al. Fluctuations of histone chemical modifications in breast, prostate, and colorectal cancer: an implication of phytochemicals as defenders of chromatin equilibrium. Biomolecules. 2019;9.

  133. 133.

    Proniuk S, Liederer BM, Blanchard J. Preformulation study of epigallocatechin gallate, a promising antioxidant for topical skin cancer prevention. J Pharm Sci. 2002;91:111–6.

    CAS  Article  PubMed  Google Scholar 

  134. 134.

    Ndiaye M, Kumar R, Ahmad N. Resveratrol in cancer management: where are we and where we go from here? Ann N Y Acad Sci. 2011;1215:144–9.

    CAS  Article  PubMed  Google Scholar 

  135. 135.

    Mukherjee S, Dudley JI, Das DK. Dose-dependency of resveratrol in providing health benefits. Dose-Response Publ Int Hormesis Soc. 2010;8:478–500.

    CAS  Article  Google Scholar 

  136. 136.

    Shawkey AM, Rabeh MA, Abdulall AK, Abdellatif AO. Green nanotechnology: anticancer activity of silver nanoparticles using Citrullus colocynthis aqueous extracts. 2013;13:12.

  137. 137.

    Khoobchandani M, Zambre A, Katti K, Lin C-H, Katti KV. Green nanotechnology from brassicaceae: development of broccoli phytochemicals–encapsulated gold nanoparticles and their applications in nanomedicine. Int J Green Nanotechnol. 2013;1:1943089213509474.

    Article  Google Scholar 

  138. 138.

    Katti K, Chanda N, Shukla R, Zambre A, Suibramanian T, Kulkarni RR, et al. Green nanotechnology from cumin phytochemicals: generation of biocompatible gold nanoparticles. Int J Green Nanotechnol Biomed. 2009;1:B39–52.

    Article  PubMed  PubMed Central  Google Scholar 

  139. 139.

    Al-Sheddi ES, Farshori NN, Al-Oqail MM, Al-Massarani SM, Saquib Q, Wahab R, Musarrat J, Al-Khedhairy AA, Siddiqui MA. Anticancer potential of green synthesized silver nanoparticles using extract of Nepeta deflersiana against human cervical cancer cells (HeLA) Available online: (accessed on Mar 2, 2020).

  140. 140.

    Prasad KS, Patel H, Patel T, Patel K, Selvaraj K. Biosynthesis of Se nanoparticles and its effect on UV-induced DNA damage. Colloids Surf B: Biointerfaces. 2013;103:261–6.

    CAS  Article  PubMed  Google Scholar 

  141. 141.

    Kumar S, Meena R, Rajamani P. Fabrication of BSA-green tea polyphenols-chitosan nanoparticles and their role in radioprotection: a molecular and biochemical approach. J Agric Food Chem. 2016;64:6024–34.

    CAS  Article  PubMed  Google Scholar 

  142. 142.

    Chandrasekharan DK, Nair CKK. Effect of silver nanoparticle and glycyrrhizic acid (SN-GLY) complex on repair of whole body radiation-induced cellular DNA damage and genomic instability in mice. Int J Low Radiat. 2010;7:453.

    CAS  Article  Google Scholar 

  143. 143.

    Shukla Y, Srivastava, Bhatnagar, Singh, Mishra, Kumar. Gupta Synthesis of PLGA nanoparticles of tea polyphenols and their strong in vivo protective effect against chemically induced DNA damage. Int J Nanomedicine. 2013;1451.

  144. 144.

    Das J, Das S, Samadder A, Bhadra K, Khuda-Bukhsh AR. Poly (lactide-co-glycolide) encapsulated extract of Phytolacca decandra demonstrates better intervention against induced lung adenocarcinoma in mice and on A549 cells. Eur J Pharm Sci. 2012;47:313–24.

    CAS  Article  PubMed  Google Scholar 

  145. 145.

    Vazquez-Muñoz R, Borrego B, Juárez-Moreno K, García-García M, Mota Morales JD, Bogdanchikova N, et al. Toxicity of silver nanoparticles in biological systems: does the complexity of biological systems matter? Toxicol Lett. 2017;276:11–20.

    CAS  Article  PubMed  Google Scholar 

  146. 146.

    Cho Y-M, Mizuta Y, Akagi J, Toyoda T, Sone M, Ogawa K. Size-dependent acute toxicity of silver nanoparticles in mice. J Toxicol Pathol. 2018;31:73–80.

    CAS  Article  PubMed  Google Scholar 

  147. 147.

    Haase A, Tentschert J, Jungnickel H, Graf P, Mantion A, Draude F, et al. Toxicity of silver nanoparticles in human macrophages: uptake, intracellular distribution and cellular responses. J Phys Conf Ser. 2011;304:012030.

    CAS  Article  Google Scholar 

  148. 148.

    Hudecova A, Kusznierewicz B, Runden-Pran E, Magdolenova Z, Hasplova K, Rinna A, et al. Silver nanoparticles induce premutagenic DNA oxidation that can be prevented by phytochemicals from Gentiana asclepiadea. Mutagenesis. 2012;27:759–69.

    CAS  Article  PubMed  Google Scholar 

  149. 149.

    Gill CIR, Haldar S, Boyd LA, Bennett R, Whiteford J, Butler M, et al. Watercress supplementation in diet reduces lymphocyte DNA damage and alters blood antioxidant status in healthy adults. Am J Clin Nutr. 2007;85:504–10.

    CAS  Article  PubMed  Google Scholar 

  150. 150.

    Weisel T, Baum M, Eisenbrand G, Dietrich H, Will F, Stockis J-P, et al. An anthocyanin/polyphenolic-rich fruit juice reduces oxidative DNA damage and increases glutathione level in healthy probands. Biotechnol J. 2006;1:388–97.

    CAS  Article  PubMed  Google Scholar 

  151. 151.

    Luo H, Tang L, Tang M, Billam M, Huang T, Yu J, et al. Phase IIa chemoprevention trial of green tea polyphenols in high-risk individuals of liver cancer: modulation of urinary excretion of green tea polyphenols and 8-hydroxydeoxyguanosine. Carcinogenesis. 2006;27:262–8.

    CAS  Article  PubMed  Google Scholar 

  152. 152.

    Schlotz N, Odongo GA, Herz C, Waßmer H, Kühn C, Hanschen FS, et al. Are raw brassica vegetables healthier than cooked ones? A randomized, controlled crossover intervention trial on the health-promoting potential of Ethiopian Kale. Nutrients. 2018;10.

  153. 153.

    Shaughnessy DT, Gangarosa LM, Schliebe B, Umbach DM, Xu Z, MacIntosh B, et al. Inhibition of fried meat-induced colorectal DNA damage and altered systemic genotoxicity in humans by crucifera, chlorophyllin, and yogurt. PLoS ONE. 2011;6.

  154. 154.

    Pichler C, Ferk F, Al-Serori H, Huber W, Jäger W, Waldherr M, et al. Xanthohumol prevents DNA damage by dietary carcinogens: results of a human intervention trial. Cancer Prev Res (Phila). 2017;10:153–60.

    CAS  Article  Google Scholar 

  155. 155.

    Steinkellner H, Hoelzl C, Uhl M, Cavin C, Haidinger G, Gsur A, et al. Coffee consumption induces GSTP in plasma and protects lymphocytes against (+/-)-anti-benzo[a]pyrene-7,8-dihydrodiol-9,10-epoxide induced DNA-damage: results of controlled human intervention trials. Mutat Res. 2005;591:264–75.

    CAS  Article  PubMed  Google Scholar 

  156. 156.

    Hoelzl C, Glatt H, Meinl W, Sontag G, Haidinger G, Kundi M, et al. Consumption of Brussels sprouts protects peripheral human lymphocytes against 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) and oxidative DNA-damage: results of a controlled human intervention trial. Mol Nutr Food Res. 2008;52:330–41.

    CAS  Article  PubMed  Google Scholar 

  157. 157.

    Riso P, Martini D, Visioli F, Martinetti A, Porrini M. Effect of broccoli intake on markers related to oxidative stress and cancer risk in healthy smokers and nonsmokers. Nutr Cancer. 2009;61:232–7.

    CAS  Article  PubMed  Google Scholar 

  158. 158.

    Placzek M, Gaube S, Kerkmann U, Gilbertz K-P, Herzinger T, Haen E, et al. Ultraviolet B-induced DNA damage in human epidermis is modified by the antioxidants ascorbic acid and D-α-tocopherol. J Invest Dermatol. 2005;124:304–7.

    CAS  Article  PubMed  Google Scholar 

  159. 159.

    Jaeger RG. Historic development of the knowledge on radiation injury and radiation protection in medical x-ray institutions during the last 75 years. Rontgenpraxis Z Radiol Tech. 1970;23:298–305.

    CAS  Google Scholar 

  160. 160.

    Sansare K, Khanna V, Karjodkar F. Early victims of X-rays: a tribute and current perception. Dento Maxillo Facial Radiol. 2011;40:123–5.

    CAS  Article  Google Scholar 

  161. 161.

    Walker JS. The controversy over radiation safety. A historical overview. JAMA. 1989;262:664–8.

    CAS  Article  Google Scholar 

  162. 162.

    Hensley ML, Hagerty KL, Kewalramani T, Green DM, Meropol NJ, Wasserman TH, et al. American Society of Clinical Oncology 2008 clinical practice guideline update: use of chemotherapy and radiation therapy protectants. J Clin Oncol Off J Am Soc Clin Oncol. 2009;27:127–45.

    CAS  Article  Google Scholar 

  163. 163.

    Hensley ML, Schuchter LM, Lindley C, Meropol NJ, Cohen GI, Broder G, et al. American Society of Clinical Oncology clinical practice guidelines for the use of chemotherapy and radiotherapy protectants. J Clin Oncol Off J Am Soc Clin Oncol. 1999;17:3333–55.

    CAS  Article  Google Scholar 

  164. 164.

    Fu B, Wang N, Tan H-Y, Li S, Cheung F, Feng Y. Multi-component herbal products in the prevention and treatment of chemotherapy-associated toxicity and side effects: a review on experimental and clinical evidences. Front Pharmacol. 2018;9:1394.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  165. 165.

    Balneaves LG, Weeks L, Seely D. Patient decision-making about complementary and alternative medicine in cancer management: context and process. Curr Oncol Tor Ont. 2008;15(Suppl 2):s94–s100.

    Article  Google Scholar 

  166. 166.

    Balneaves LG, Truant TLO, Kelly M, Verhoef MJ, Davison BJ. Bridging the gap: decision-making processes of women with breast cancer using complementary and alternative medicine (CAM). Support Care Cancer Off J Multinatl Assoc Support Care Cancer. 2007;15:973–83.

    Article  Google Scholar 

  167. 167.

    Smith TA, Kirkpatrick DR, Smith S, Smith TK, Pearson T, Kailasam A, et al. Radioprotective agents to prevent cellular damage due to ionizing radiation. J Transl Med. 2017;15:232.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  168. 168.

    Jagetia GC. Radioprotective potential of plants and herbs against the effects of ionizing radiation. J Clin Biochem Nutr. 2007;40:74–81.

    CAS  Article  Google Scholar 

  169. 169.

    Hazra B, Ghosh S, Kumar A, Pandey BN. The prospective role of plant products in radiotherapy of cancer: a current overview. Front Pharmacol. 2011;2:94.

    Article  PubMed  Google Scholar 

  170. 170.

    Velauthapillai N, Barfett J, Jaffer H, Mikulis D, Murphy K. Antioxidants taken orally prior to diagnostic radiation exposure can prevent DNA injury. J Vasc Interv Radiol JVIR. 2017;28:406–11.

    Article  PubMed  Google Scholar 

  171. 171.

    Seibold P, Webb A, Aguado-Barrera ME, Azria D, Bourgier C, Brengues M, et al. REQUITE: a prospective multicentre cohort study of patients undergoing radiotherapy for breast, lung or prostate cancer. Radiother Oncol J Eur Soc Ther Radiol Oncol. 2019;138:59–67.

    Article  Google Scholar 

  172. 172.

    Clémenson C, Liu W, Bricout D, Soyez-Herkert L, Chargari C, Mondini M, et al. Preventing radiation-induced injury by topical application of an amifostine metabolite-loaded thermogel. Int J Radiat Oncol Biol Phys. 2019;104:1141–52.

    CAS  Article  PubMed  Google Scholar 

  173. 173.

    Elting LS, Chang Y-C. Costs of oral complications of cancer therapies: estimates and a blueprint for future study. J Natl Cancer Inst Monogr. 2019;2019.

  174. 174.

    Raeessi MA, Raeessi N, Panahi Y, Gharaie H, Davoudi SM, Saadat A, et al. “Coffee plus honey” versus “topical steroid” in the treatment of chemotherapy-induced oral mucositis: a randomised controlled trial. BMC Complement Altern Med. 2014;14:293.

    Article  PubMed  PubMed Central  Google Scholar 

  175. 175.

    Babaee N, Moslemi D, Khalilpour M, Vejdani F, Moghadamnia Y, Bijani A, et al. Antioxidant capacity of calendula officinalis flowers extract and prevention of radiation induced oropharyngeal mucositis in patients with head and neck cancers: a randomized controlled clinical study. Daru J Fac Pharm Tehran Univ Med Sci. 2013;21:18.

    Article  Google Scholar 

  176. 176.

    Aghamohamamdi A, Hosseinimehr SJ. Natural products for management of oral mucositis induced by radiotherapy and chemotherapy. Integr Cancer Ther. 2016;15:60–8.

    CAS  Article  PubMed  Google Scholar 

  177. 177.

    Ryan JL, Heckler CE, Ling M, Katz A, Williams JP, Pentland AP, et al. Curcumin for radiation dermatitis: a randomized, double-blind, placebo-controlled clinical trial of thirty breast cancer patients. Radiat Res. 2013;180:34–43.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  178. 178.

    Yasueda A, Urushima H, Ito T. Efficacy and interaction of antioxidant supplements as adjuvant therapy in cancer treatment: a systematic review. Integr Cancer Ther. 2016;15:17–39.

    CAS  Article  PubMed  Google Scholar 

  179. 179.

    Zhang Q-Y, Wang F-X, Jia K-K, Kong L-D. Natural product interventions for chemotherapy and radiotherapy-induced side effects. Front Pharmacol. 2018;9:1253.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  180. 180.

    Harvie M. Nutritional supplements and cancer: potential benefits and proven harms. Am Soc Clin Oncol Educ Book Am Soc Clin Oncol Annu Meet. 2014:e478–86.

  181. 181.

    Meyer F, Bairati I, Fortin A, Gélinas M, Nabid A, Brochet F, et al. Interaction between antioxidant vitamin supplementation and cigarette smoking during radiation therapy in relation to long-term effects on recurrence and mortality: a randomized trial among head and neck cancer patients. Int J Cancer. 2008;122:1679–83.

    CAS  Article  PubMed  Google Scholar 

  182. 182.

    Tiwari P, Mishra KP. Flavonoids sensitize tumor cells to radiation: molecular mechanisms and relevance to cancer radiotherapy. Int J Radiat Biol. 2020;96:360–9.

    CAS  Article  PubMed  Google Scholar 

  183. 183.

    Taixiang W, Munro AJ, Guanjian L. Chinese medical herbs for chemotherapy side effects in colorectal cancer patients. Cochrane Database Syst Rev. 2005:CD004540.

  184. 184.

    Spadacio C, Barros NF. de [Use of complementary and alternative medicine by cancer patients: systematic review]. Rev Saude Publica. 2008;42:158–64.

    Article  PubMed  Google Scholar 

  185. 185.

    Smith PJ, Clavarino A, Long J, Steadman KJ. Why do some cancer patients receiving chemotherapy choose to take complementary and alternative medicines and what are the risks? Asia Pac J Clin Oncol. 2014;10:1–10.

    Article  PubMed  Google Scholar 

  186. 186.

    Ramos-Esquivel A, Víquez-Jaikel Á, Fernández C. Potential drug-drug and herb-drug interactions in patients with cancer: a prospective study of medication surveillance. J Oncol Pract. 2017;13:e613–22.

    Article  PubMed  Google Scholar 

  187. 187.

    Jermini M, Dubois J, Rodondi P-Y, Zaman K, Buclin T, Csajka C, et al. L Complementary medicine use during cancer treatment and potential herb-drug interactions from a cross-sectional study in an academic centre. Sci Rep. 2019;9:5078.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  188. 188.

    Sparreboom A, Cox MC, Acharya MR, Figg WD. Herbal remedies in the United States: potential adverse interactions with anticancer agents. J Clin Oncol Off J Am Soc Clin Oncol. 2004;22:2489–503.

    CAS  Article  Google Scholar 

  189. 189.

    Argyriou AA, Chroni E, Koutras A, Iconomou G, Papapetropoulos S, Polychronopoulos P, et al. A randomized controlled trial evaluating the efficacy and safety of vitamin E supplementation for protection against cisplatin-induced peripheral neuropathy: final results. Support Care Cancer Off J Multinatl Assoc Support Care Cancer. 2006;14:1134–40.

    Article  Google Scholar 

  190. 190.

    Weijl NI, Elsendoorn TJ, Lentjes EGWM, Hopman GD, Wipkink-Bakker A, Zwinderman AH, et al. Supplementation with antioxidant micronutrients and chemotherapy-induced toxicity in cancer patients treated with cisplatin-based chemotherapy: a randomised, double-blind, placebo-controlled study. Eur J Cancer Oxf Engl. 1990;40(2004):1713–23.

    CAS  Article  Google Scholar 

  191. 191.

    Prasad KN. Multiple dietary antioxidants enhance the efficacy of standard and experimental cancer therapies and decrease their toxicity. Integr Cancer Ther. 2004;3:310–22.

    CAS  Article  PubMed  Google Scholar 

  192. 192.

    Siddiqui JA, Singh A, Chagtoo M, Singh N, Godbole MM, Chakravarti B. Phytochemicals for breast cancer therapy: current status and future implications. Curr Cancer Drug Targets. 2015;15:116–35.

    CAS  Article  PubMed  Google Scholar 

  193. 193.

    Wu AH, Lee E, Vigen C. Soy isoflavones and breast cancer. Am Soc Clin Oncol Educ. Book Am Soc Clin Oncol Annu Meet. 2013:102–6.

  194. 194.

    Toledo E, Salas-Salvadó J, Donat-Vargas C, Buil-Cosiales P, Estruch R, Ros E, et al. Mediterranean diet and invasive breast cancer risk among women at high cardiovascular risk in the PREDIMED trial: a randomized clinical trial. JAMA Intern Med. 2015;175:1752–60.

    Article  PubMed  Google Scholar 

  195. 195.

    Kapinova A, Kubatka P, Golubnitschaja O, Kello M, Zubor P, Solar P, et al. Dietary phytochemicals in breast cancer research: anticancer effects and potential utility for effective chemoprevention. Environ Health Prev Med. 2018;23.

  196. 196.

    Schenberg EE. Ayahuasca and cancer treatment. SAGE Open Med. 2013;1:2050312113508389.

    Article  PubMed  PubMed Central  Google Scholar 

  197. 197.

    Jalili-Nik M, Sabri H, Zamiri E, Soukhtanloo M, Roshan MK, Hosseini A, et al. Cytotoxic effects of ferula Latisecta on human glioma U87 cells. Drug Res. 2019;69:665–70.

    CAS  Article  Google Scholar 

  198. 198.

    Kocyigit A, Aydogdu G, Balkan E, Yenigun VB, Guler EM, Bulut H, et al. Quercus pyrenaica honeydew honey with high phenolic contents cause DNA damage, apoptosis, and cell death through generation of reactive oxygen species in gastric adenocarcinoma cells. Integr Cancer Ther. 2019;18.

  199. 199.

    D’Souza LC, Mishra S, Chakraborty A, Shekher A, Sharma A, Gupta SC. Oxidative stress and cancer development: are noncoding RNAs the missing links? Antioxid Redox Signal. 2020.

  200. 200.

    Fenton SE, Birnbaum LS. Timing of environmental exposures as a critical element in breast cancer risk. J Clin Endocrinol Metab. 2015;100:3245–50.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  201. 201.

    Kunin A, Polivka J, Moiseeva N, Golubnitschaja O. “Dry mouth” and “Flammer” syndromes—neglected risks in adolescents and new concepts by predictive, preventive and personalised approach. EPMA J. 2018;9:307–17.

    Article  PubMed  PubMed Central  Google Scholar 

  202. 202.

    Golubnitschaja O, Baban B, Boniolo G, Wang W, Bubnov R, Kapalla M, et al. Medicine in the early twenty-first century: paradigm and anticipation-EPMA position paper 2016. EPMA J. 2016;7:23.

    Article  PubMed  PubMed Central  Google Scholar 

  203. 203.

    Guéraud F, Taché S, Steghens J-P, Milkovic L, Borovic-Sunjic S, Zarkovic N, et al. Dietary polyunsaturated fatty acids and heme iron induce oxidative stress biomarkers and a cancer promoting environment in the colon of rats. Free Radic Biol Med. 2015;83:192–200.

    CAS  Article  PubMed  Google Scholar 

  204. 204.

    Wang X, Ding N, Tucker KL, Weisskopf MG, Sparrow D, Hu H, et al. A Western diet pattern is associated with higher concentrations of blood and bone lead among middle-aged and elderly men. J Nutr. 2017;147:1374–83.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  205. 205.

    Shin S, Saito E, Sawada N, Ishihara J, Takachi R, Nanri A, et al. Dietary patterns and colorectal cancer risk in middle-aged adults: a large population-based prospective cohort study. Clin Nutr Edinb Scotl. 2018;37:1019–26.

    Article  Google Scholar 

  206. 206.

    Martini D. Health benefits of Mediterranean diet. Nutrients. 2019:11.

  207. 207.

    McClish D, Carcaise-Edinboro P, Esinhart H, Wilson DB, Bean MK. Differences in response to a dietary intervention between the general population and first-degree relatives of colorectal cancer patients. J Nutr Educ Behav. 2014;46:376–83.

    Article  PubMed  PubMed Central  Google Scholar 

  208. 208.

    Bubnov RV, Spivak MY, Lazarenko LM, Bomba A, Boyko NV. Probiotics and immunity: provisional role for personalized diets and disease prevention. EPMA J. 2015;6:14.

    Article  PubMed  PubMed Central  Google Scholar 

  209. 209.

    Bubnov R, Babenko L, Lazarenko L, Kryvtsova M, Shcherbakov O, Zholobak N, et al. Can tailored nanoceria act as a prebiotic? Report on improved lipid profile and gut microbiota in obese mice. EPMA J. 2019;10:317–35.

    Article  PubMed  Google Scholar 

  210. 210.

    Mansour-Ghanaei F, Varshi G, Joukar F, Ashoobi MT, Esmaeilpour J, Gharibpoor A, et al. Prevalence of pre-cancerous colon lesions in referred patients under patronage of a local relief foundation in Guilan province. J Med Life. 2019;12:133–9.

    Article  PubMed  PubMed Central  Google Scholar 

  211. 211.

    Aussem A, Ludwig K. The potential for reducing Lynch syndrome cancer risk with nutritional Nrf2 activators. Nutr Cancer. 2020:1–16.

  212. 212.

    Singh S, Sharma B, Kanwar SS, Kumar A. Lead phytochemicals for anticancer drug development. Front Plant Sci. 2016;7.

  213. 213.

    Tantengco OAG, Jacinto SD. Cytotoxic activity of crude extracts and fractions from Premna odorata (Blanco), Artocarpus camansi (Blanco) and Gliricidia sepium (Jacq.) against selected human cancer cell lines. Asian Pac J Trop Biomed. 2015;5:1037–41.

    CAS  Article  Google Scholar 

  214. 214.

    Somwong P, Suttisri R. Cytotoxic activity of the chemical constituents of Clerodendrum indicum and Clerodendrum villosum roots. J Integr Med. 2018;16:57–61.

    Article  PubMed  Google Scholar 

  215. 215.

    Tong J, Shen Y, Zhang Z, Hu Y, Zhang X, Han L. Apigenin inhibits epithelial-mesenchymal transition of human colon cancer cells through NF-κB/Snail signaling pathway. Biosci Rep. 2019;39.

  216. 216.

    Buhrmann C, Popper B, Kunnumakkara AB, Aggarwal BB, Shakibaei M. Evidence that Calebin A, a component of Curcuma Longa suppresses NF-B mediated proliferation, invasion and metastasis of human colorectal cancer induced by TNF-β (Lymphotoxin). Nutrients. 2019;11.

  217. 217.

    Sagar SM. Integrative oncology in North America. J Soc Integr Oncol. 2006;4:27–39.

    PubMed  Google Scholar 

  218. 218.

    Alsanad SM, Howard RL, Williamson EM. An assessment of the impact of herb-drug combinations used by cancer patients. BMC Complement Altern Med. 2016;16:393.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  219. 219.

    Zhang L, Peng Y, Uray IP, Shen J, Wang L, Peng X, et al. Natural product β-thujaplicin inhibits homologous recombination repair and sensitizes cancer cells to radiation therapy. DNA Repair. 2017;60:89–101.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  220. 220.

    Zubair H, Azim S, Ahmad A, Khan M, Patel G, Singh S, et al. Cancer chemoprevention by phytochemicals: nature’s healing touch. Molecules. 2017;22:395.

    CAS  Article  PubMed Central  Google Scholar 

  221. 221.

    Ranjan A, Ramachandran S, Gupta N, Kaushik I, Wright S, Srivastava S, et al. Role of phytochemicals in cancer prevention. Int J Mol Sci. 2019:20.

  222. 222.

    Jiang F, Li Y, Mu J, Hu C, Zhou M, Wang X, et al. Glabridin inhibits cancer stem cell-like properties of human breast cancer cells: an epigenetic regulation of miR-148a/SMAd2 signaling. Mol Carcinog. 2016;55:929–40.

    CAS  Article  PubMed  Google Scholar 

  223. 223.

    Patterson SL, Colbert Maresso K, Hawk E. Cancer chemoprevention: successes and failures. Clin Chem. 2013;59:94–101.

    CAS  Article  PubMed  Google Scholar 

  224. 224.

    Zhang Z, Bien J, Mori M, Jindal S, Bergan R. A way forward for cancer prevention therapy: personalized risk assessment. Oncotarget. 2019;10:6898–912.

    Article  PubMed  PubMed Central  Google Scholar 

  225. 225.

    Flammer syndrome: from phenotype to associated pathologies, prediction, prevention and personalisation; Golubnitschaja, O., Ed.; Advances in Predictive, Preventive and Personalised Medicine; Springer International Publishing: Cham, 2019; Vol. 11; ISBN 978-3-030-13549-2.

  226. 226.

    Lu M, Zhan X. The crucial role of multiomic approach in cancer research and clinically relevant outcomes. EPMA J. 2018;9:77–102.

    Article  PubMed  PubMed Central  Google Scholar 

  227. 227.

    Valle I, Tramalloni D, Bragazzi NL. Cancer prevention: state of the art and future prospects. J Prev Med Hyg. 2015;56:E21–7.

    CAS  PubMed  PubMed Central  Google Scholar 

  228. 228.

    Golubnitschaja O, Debald M, Yeghiazaryan K, Kuhn W, Pešta M, Costigliola V, et al. Breast cancer epidemic in the early twenty-first century: evaluation of risk factors, cumulative questionnaires and recommendations for preventive measures. Tumor Biol. 2016;37:12941–57.

    Article  Google Scholar 

  229. 229.

    Uramova S, Kubatka P, Dankova Z, Kapinova A, Zolakova B, Samec M, et al. Plant natural modulators in breast cancer prevention: status quo and future perspectives reinforced by predictive, preventive, and personalized medical approach. EPMA J. 2018;9:403–19.

    Article  PubMed  PubMed Central  Google Scholar 

  230. 230.

    Qian S, Golubnitschaja O, Zhan X. Chronic inflammation: key player and biomarker-set to predict and prevent cancer development and progression based on individualized patient profiles. EPMA J. 2019;10(4):365–81.

  231. 231.

    Janssens J Ph, Schuster K, Voss A. Preventive, predictive, and personalized medicine for effective and affordable cancer care. EPMA J. 2018;9(2):113–23.

  232. 232.

    Polivka J, Altun I, Golubnitschaja O. Pregnancy-associated breast cancer: the risky status quo and new concepts of predictive medicine. EPMA J. 2018;9(1):1–13.

Download references


Open Access funding provided by Projekt DEAL. This work was supported by the Scientific Grant Agency of the Ministry of Education of the Slovak Republic under the Contracts No. VEGA 1/0136/19 and the Slovak Research and Development Agency under the Contract No. APVV-16-0021. This publication resulted from the project implementation: “CENTER OF EXCELLENCE FOR RESEARCH IN PERSONALIZED THERAPY (CEVYPET),” ITMS: 26220120053 supported by the Operational Programme Research and Innovation funded by the ERDF“. D. B. was supported by a National Priorities Research Program grant (NPRP 11S-1214-170101; awarded to D.B.; June 2019—current) from the Qatar National Research Fund (QNRF, a member of Qatar Foundation).

Author information




L.K., A.L., M.S., P.K., A.Z., T.Q., K.S., K.K., J.J., and M.P. performed the literature search and wrote the manuscript; P.K., D.B., and T.K.K. provided a skilled assistance and supervised the overall preparation of the manuscript; L.K. and M.S. proposed and prepared the figures; P.K., O.G., A.L., K.B., and P.B. contributed to the overall paper concepts, literature search, and manuscript editing; P.K., O.G., D.B., T.K.K., J.D., P.Z., G.S., and F.G. elaborated on the final version of the manuscript.

Corresponding authors

Correspondence to Olga Golubnitschaja or Peter Kubatka.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Koklesova, L., Liskova, A., Samec, M. et al. Genoprotective activities of plant natural substances in cancer and chemopreventive strategies in the context of 3P medicine. EPMA Journal 11, 261–287 (2020).

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI:


  • Predictive Preventive Personalised Medicine (3PM, PPPM)
  • Oncology
  • Tumour
  • Plant natural substances
  • Phytochemicals
  • Antimutagenic effects
  • Genomic instability
  • Genotoxicity
  • Prebiotic
  • Probiotic
  • Anti-inflammatory
  • Antioxidant
  • Antibacterial
  • Antifungal
  • Anticancer
  • Beneficiary effects
  • Genoprotection
  • Chemoprevention
  • Superoxide dismutase
  • Hydrogen peroxide
  • Glutathione
  • Thioredoxin
  • Glutaredoxins
  • ROS
  • Scavanger
  • Preclinical and clinical study
  • Exogenous and endogenous agents
  • Oxidative stress
  • Biomarkers
  • Therapeutic potential
  • Diet
  • Nanoparticles
  • Nanotechnology
  • Detoxification
  • Breast cancer
  • Colon cancer